As filed with the Securities and Exchange Commission
on September 13, 2024
Securities Act File No. 333-269889
Investment Company Act File No. 811-21465
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
N-2
(CHECK APPROPRIATE BOX OR BOXES)
☒ |
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 |
|
|
|
|
☐ |
Pre-Effective Amendment No. |
|
|
|
|
☒ |
Post-Effective Amendment No. 3 |
|
|
|
|
☒ |
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 |
|
|
|
|
☒ |
Amendment No. 13 |
|
CBRE Global Real Estate Income Fund
(Exact name of Registrant as specified in
Charter)
555
East Lancaster Avenue, Suite 120
Radnor, Pennsylvania
19087
(Address of principal
executive offices)
(877) 711-4272
(Registrant’s
Telephone Number, including Area Code)
Joseph P. Smith, President and Principal Executive
Officer
CBRE Global Real Estate Income Fund
555 East Lancaster
Avenue, Suite 120
Radnor, Pennsylvania 19087
(Name and Address of Agent for Service)
Copies To:
Thomas S. Harman
Morgan, Lewis & Bockius LLP
1111 Pennsylvania Avenue NW
Washington, DC 20004
Approximate Date of Proposed
Public Offering: From time to time after the effective date of the Registration Statement.
☐ Check
box if the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans.
☒ Check
box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415 under the
Securities Act of 1933 (“Securities Act”) other than securities offered in connection with a dividend reinvestment plan.
☐ Check
box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto.
☐ Check
box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become
effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act.
☐ Check
box if this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional
securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act.
It is proposed that
this filing will become effective (check appropriate box):
☐ when
declared effective pursuant to Section 8(c) of the Securities Act.
If appropriate, check
the following box:
☐ This
post-effective amendment designates a new effective date for a previously filed post-effective amendment.
☐ This
Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and the Securities Act
registration statement number of the earlier effective registration statement for the same offering is: .
☐ This
Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement
number of the earlier effective registration statement for the same offering is: .
☒ This
Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement
number of the earlier effective registration statement for the same offering is: 333-269889.
Check each box that
appropriately characterizes the Registrant:
☒ Registered
Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (“Investment Company Act”)).
☐ Business
Development Company (closed-end company that intends or has elected to be regulated as a business development company under the Investment
Company Act).
☐ Interval
Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase offers under Rule 23c-3 under the Investment
Company Act).
☒ A.2
Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).
☒ Well-Known
Seasoned Issuer (as defined by Rule 405 under the Securities Act).
☐ Emerging
Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of 1934 (“Exchange Act”).
☐ If
an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act.
☐ New
Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing).
EXPLANATORY NOTE
This Post-Effective Amendment
No. 3 to CBRE Global Real Estate Income Fund’s (the “Registrant”) Registration Statement on Form N-2 (File No. 333-269889)
(the “Registration Statement”) is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the “Securities
Act”), solely for the purpose of filing certain exhibits to the Registration Statement. Accordingly, this Post-Effective Amendment
No. 3 to the Registration Statement consists only of a facing page, this explanatory note, and Part C. The Registrant hereby incorporates
by reference the Prospectus
and Statement of Additional
Information, filed as Parts A and B, respectively, in the Registrant’s Registration Statement on Form N-2, as filed with the
U.S. Securities and Exchange Commission (the “SEC”) on February 21, 2023 (Accession No. 0001174947-23-000233).
As permitted by Rule
462(d) under the Securities Act, this Post-Effective Amendment No. 3 shall become effective upon filing with the SEC.
PART C – OTHER INFORMATION
| Item 25. | Financial Statements and Exhibits |
1. Financial Statements.
Part A — Financial Highlights for the fiscal
years ended December 31, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, and 2013.
Part B — Financial
Statements included in the audited Annual Report on Form N-CSR for the fiscal year ended December 31, 2022, filed with the SEC
on February 21, 2023 (EDGAR Accession No. 0001193125-23-043544) (incorporated into Part B by reference).
2. Exhibits.
(a)(1) |
Certificate of Trust of CBRE Global Real Estate Income Fund (the “Registrant” or the “Trust”), dated November 6, 2003, as amended July 1, 2011 and September 30, 2021, is incorporated herein by reference to Exhibit (a)(1) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(a)(2) |
Amended and Restated Agreement and Declaration of Trust of the Registrant, dated as of September 30, 2021 (the “Agreement and Declaration of Trust”), is incorporated herein by reference to Exhibit (a) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
|
|
(b) |
Amended and Restated By-Laws of the Registrant, dated as of June 7, 2024, are incorporated herein by reference to Exhibit (b) to Post-Effective Amendment No. 2 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001213900-24-058533 on July 2, 2024. |
|
|
(c) |
Not applicable. |
|
|
(d)(1) |
See Article VI of the Agreement and Declaration of Trust filed as Exhibit (a)(2) above. |
|
|
(d)(2) |
Form of Subscription Certificate is incorporated herein by reference to Exhibit (d)(2) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(d)(3) |
Form of Notice of Guaranteed Delivery is incorporated herein by reference to Exhibit (d)(3) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(e) |
Automatic Dividend Reinvestment Plan, adopted February 27, 2004, is incorporated herein by reference to Exhibit (e) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
(f) |
Inapplicable. |
|
|
(g)(1) |
Investment Management Agreement, dated February 18, 2004, between the Registrant and ING Clarion Real Estate Securities, L.P. (now, CBRE Investment Management Listed Real Assets LLC) is incorporated herein by reference to Exhibit (g)(1) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
|
|
(g)(2) |
Waiver Reliance Letter, dated February 18, 2004, between the Registrant and ING Clarion Global Real Estate Securities, L.P. (now, CBRE Investment Management Listed Real Assets LLC) is incorporated herein by reference to Exhibit (g)(2) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
|
|
(h)(1) |
Additional Compensation Agreement, dated February 24, 2004, between ING Clarion Real Estate Securities, L.P. (now, CBRE Investment Management Listed Real Assets LLC) and A.G. Edwards & Sons, Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, UBS Securities LLC, and Wachovia Capital Markets, LLC (the “Additional Compensation Agreement”) is incorporated herein by reference to Exhibit (h)(3) to Pre-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-1A (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-07-000024 on January 4, 2007. |
|
|
(h)(2) |
Amendment No. 1, dated September 17, 2010, to the Additional Compensation Agreement is incorporated herein by reference to Exhibit (h)(2) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
|
|
(h)(3) |
Engagement Agreement, dated January 25, 2023, between the Registrant and Chatsworth Securities LLC is incorporated herein by reference to Exhibit (h)(3) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(h)(4) |
Distribution Agreement relating to at-the-market offerings, dated September 13, 2024, between the Registrant and Foreside Fund Services, LLC is filed herewith. |
|
|
(h)(5) |
Sub-Placement Agent Agreement relating to at-the-market offerings, dated September 13, 2024, between Foreside Fund Services, LLC and UBS Securities LLC is filed herewith. |
|
|
(i) |
Not applicable. |
|
|
(j) |
Custody Agreement, dated February 27, 2004, between the Registrant and The Bank of New York (now, The Bank of New York Mellon) is incorporated herein by reference to Exhibit (j) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
|
|
(k)(1) |
Blanket Issuer Letter of Representations, dated May 14, 2004, between the Registrant and The Depository Trust Company is incorporated herein by reference to Exhibit (k)(4) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
(k)(2) |
Administration Agreement, dated February 27, 2004, between the Registrant and The Bank of New York (now, The Bank of New York Mellon) is incorporated herein by reference to Exhibit (k)(5) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
|
|
(k)(3) |
Fund Accounting Agreement, dated February 27, 2004, between the Registrant and The Bank of New York (now, The Bank of New York Mellon) is incorporated herein by reference to Exhibit (k)(6) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-138660 and 811-21465), as filed with the SEC via EDGAR Accession No. 0000950153-06-002804 on November 13, 2006. |
|
|
(k)(4) |
Transfer Agency and Service Agreement, effective as of May 1, 2022, between the Registrant and Computershare, Inc. (the “Transfer Agency and Service Agreement”) is incorporated herein by reference to Exhibit (k)(4) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
|
|
(k)(5) |
Fee and Service Schedule for Stock Transfer Services, effective May 1, 2022, to the Transfer Agency Services Agreement is incorporated herein by reference to Exhibit (k)(5) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
|
|
(k)(6) |
Amended and Restated Security Agreement, dated August 2, 2021, between the Registrant and The Bank of New York Mellon is incorporated herein by reference to Exhibit (k)(6) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
|
|
(k)(7) |
Form of Subscription Agent Agreement, dated February 24, 2023, between the Registrant, Computershare Inc., and Computershare Trust Company, N.A. is incorporated herein by reference to Exhibit (k)(7) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(k)(8) |
Information Agent Agreement, dated February 22, 2023, between the Registrant and Georgeson LLC is incorporated herein by reference to Exhibit (k)(8) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(l)(1) |
Opinion and consent of counsel, Morgan, Lewis & Bockius LLP, as to the legality of the shares being registered is incorporated herein by reference to Exhibit (l)(1) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
(l)(2) |
Opinion and consent of counsel, Morgan, Lewis & Bockius LLP, as to the legality of the rights and shares, is incorporated herein by reference to Exhibit (l)(2) to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000263 on February 27, 2023. |
|
|
(m) |
Not applicable. |
|
|
(n) |
Consent of KPMG LLP is filed herewith. |
|
|
(o) |
Not applicable. |
|
|
(p) |
Not applicable. |
|
|
(q) |
Not applicable. |
|
|
(r)(1) |
Registrant’s Code of Ethics is incorporated herein by reference to Exhibit (r)(1) to Post-Effective Amendment No. 2 to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001213900-24-058533 on July 2, 2024. |
|
|
(r)(2) |
Code of Ethics of CBRE Investment Management Listed Real Assets LLC is incorporated herein by reference to Exhibit (r)(1) to the Registrant’s Registration Statement on Form N-2 (File Nos. 333-269889 and 811-21465), as filed with the SEC via EDGAR Accession No. 0001174947-23-000233 on February 21, 2023. |
|
|
(s) |
Calculation of Filing Fee Tables is filed herewith. |
|
|
(t) |
Power of Attorney is filed herewith. |
Item 26. Marketing Arrangements
Any information concerning arrangements known
to the Registrant, principal holders of Trust shares, and/or any of the Trust’s underwriters made for any of the following purposes:
(1) to limit or restrict sale of other securities of the same class as those being offered for the period of distribution; (2) to stabilize
the market for any of the securities to be offered; or (3) to hold each underwriter or dealer responsible for the distribution of his
or her participation, will be contained in the accompanying prospectus supplement, if any, and is incorporated herein by reference.
Item 27. Other Expenses of Issuance and Distribution
The following table sets forth the estimated expenses
to be incurred in connection with the offering described in this registration statement:
SEC Registration Fees | |
$ | 28,000 | |
Printing and Mailing Expenses | |
$ | 5,000 | |
Legal Fees and Expenses | |
$ | 65,000 | |
Accounting Fees | |
$ | 25,000 | |
NYSE Listing Fees | |
$ | 50,000 | |
Miscellaneous | |
$ | 0 | |
Total | |
$ | 173,000 | |
| Item 28. | Persons Controlled by or Under Common Control |
None.
| Item 29. | Number of Holders of Securities |
At July 30, 2024:
Title of Class | |
Number of
Record
Holders | |
Shares of Common Stock, par value $0.001 | |
| 48,813 | |
Article V of the Registrant’s Agreement
and Declaration of Trust provides as follows:
5.1 No Personal Liability of Shareholders,
Trustees, etc. No Shareholder of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person
in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders shall have the same limitation of personal
liability as is extended to stockholders of a private corporation for profit incorporated under the Delaware General Corporation Law.
No Trustee or officer of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person, save only liability
to the Trust or its Shareholders arising from bad faith, willful misfeasance, gross negligence or reckless disregard for his duty to such
Person; and, subject to the foregoing exception, all such Persons shall look solely to the Trust Property for satisfaction of claims of
any nature arising in connection with the affairs of the Trust. If any Shareholder, Trustee or officer, as such, of the Trust, is made
a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, he shall not, on account thereof,
be held to any personal liability. Any repeal or modification of this Section 5.1 shall not adversely affect any right or protection of
a Trustee or officer of the Trust existing at the time of such repeal or modification with respect to acts or omissions occurring prior
to such repeal or modification.
5.2 Mandatory Indemnification.
(a) The Trust hereby agrees to indemnify each person who at any time serves as a Trustee or officer of the Trust (each such person being
an “indemnitee”) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise
or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition
of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which
he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity
set forth in this Article V by reason of his having acted in any such capacity, except with respect to any matter as to which he shall
not have acted in good faith in the reasonable belief that his action was in the best interest of the Trust or, in the case of any criminal
proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee
shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i) willful
misfeasance, (ii) bad faith, (iii) gross negligence, or (iv) reckless disregard of the duties involved in the conduct of his position
(the conduct referred to in such clauses (i) through (iv) being sometimes referred to herein as “disabling conduct”). Notwithstanding
the foregoing, with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification
shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee (1) was authorized by a majority
of the Trustees or (2) was instituted by the indemnitee to enforce his or her rights to indemnification hereunder in a case in which the
indemnitee is found to be entitled to such indemnification. The rights to indemnification set forth in this Declaration shall continue
as to a person who has ceased to be a Trustee or officer of the Trust and shall inure to the benefit of his or her heirs, executors and
personal and legal representatives. No amendment or restatement of this Declaration or repeal of any of its provisions shall limit or
eliminate any of the benefits provided to any person who at any time is or was a Trustee or officer of the Trust or otherwise entitled
to indemnification hereunder in respect of any act or omission that occurred prior to such amendment, restatement or repeal.
(b) Notwithstanding
the foregoing, no indemnification shall be made hereunder unless there has been a determination (i) by a final decision on the merits
by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that
such indemnitee is entitled to indemnification hereunder or, (ii) in the absence of such a decision, by (1) a majority vote of a quorum
of those Trustees who are neither Interested Persons of the Trust nor parties to the proceeding (“Disinterested Non-Party Trustees”),
that the indemnitee is entitled to indemnification hereunder, or (2) if such quorum is not obtainable or even if obtainable, if such majority
so directs, independent legal counsel in a written opinion concludes that the indemnitee should be entitled to indemnification hereunder.
All determinations to make advance payments in connection with the expense of defending any proceeding shall be authorized and made in
accordance with the immediately succeeding paragraph (c) below.
(c) The
Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might
be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee’s good faith belief that the
standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless it is subsequently
determined that the indemnitee is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards
of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (i)
the indemnitee shall provide adequate security for his undertaking, (ii) the Trust shall be insured against losses arising by reason of
any lawful advances, or (iii) a majority of a quorum of the Disinterested Non-Party Trustees, or if a majority vote of such quorum so
direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a
full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification.
(d) The
rights accruing to any indemnitee under these provisions shall not exclude any other right which any person may have or hereafter acquire
under this Declaration, the By-Laws of the Trust, any statute, agreement, vote of stockholders or Trustees who are not Interested Persons
of the Trust or any other right to which he or she may be lawfully entitled.
(e) Subject
to any limitations provided by the 1940 Act and this Declaration, the Trust shall have the power and authority to indemnify and provide
for the advance payment of expenses to employees, agents and other Persons providing services to the Trust or serving in any capacity
at the request of the Trust to the full extent corporations organized under the Delaware General Corporation Law may indemnify or provide
for the advance payment of expenses for such Persons, provided that such indemnification has been approved by a majority of the Trustees.
5.3 No Bond Required of Trustees.
No Trustee shall, as such, be obligated to give any bond or other security for the performance of any of his duties hereunder.
5.4 No Duty of Investigation; Insurance,
etc. No purchaser, lender, transfer agent or other person dealing with the Trustees or with any officer, employee or agent of the
Trust shall be bound to make any inquiry concerning the validity of any transaction purporting to be made by the Trustees or by said officer,
employee or agent or be liable for the application of money or property paid, loaned, or delivered to or on the order of the Trustees
or of said officer, employee or agent. Every obligation, contract, undertaking, instrument, certificate, Share, other security of the
Trust, and every other act or thing whatsoever executed in connection with the Trust shall be conclusively taken to have been executed
or done by the executors thereof only in their capacity as Trustees under this Declaration or in their capacity as officers, employees
or agents of the Trust. The Trustees may maintain insurance for the protection of the Trust Property, its Shareholders, Trustees, officers,
employees and agents in such amount as the Trustees shall deem adequate to cover possible tort liability, and such other insurance as
the Trustees in their sole judgment shall deem advisable or is required by the 1940 Act.
5.5 Reliance on Experts, etc.
Each Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully and completely justified and protected
with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Trust,
upon an opinion of counsel, or upon reports made to the Trust by any of the Trust’s officers or employees or by any advisor, administrator,
manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Trustees,
officers or employees of the Trust, regardless of whether such counsel or expert may also be a Trustee.
Section 9 of the Registrant’s Investment
Advisory Agreement provides as follows:
(a) The Trust hereby agrees to
indemnify the Advisor, and each of the Advisor’s directors, officers, employees, agents, associates and controlling persons and
the directors, partners, members, officers, employees and agents thereof (including any individual who serves at the Advisor’s request
as director, officer, partner, member, trustee or the like of another entity) (each such person being an “Indemnitee”) against
any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel
fees (all as provided in accordance with applicable state law) reasonably incurred by such Indemnitee in connection with the defense or
disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body
in which such Indemnitee may be or may have been involved as a party or otherwise or with which such Indemnitee may be or may have been
threatened, while acting in any capacity set forth herein or thereafter by reason of such Indemnitee having acted in any such capacity,
except with respect to any matter as to which such Indemnitee shall have been adjudicated not to have acted in good faith in the reasonable
belief that such Indemnitee’s action was in the best interest of the Trust and furthermore, in the case of any criminal proceeding,
so long as such Indemnitee had no reasonable cause to believe that the conduct was unlawful; provided, however, that (1) no Indemnitee
shall be indemnified hereunder against any liability to the Trust or its shareholders or any expense of such Indemnitee arising by reason
of (i) willful misfeasance, (ii) bad faith, (iii) gross negligence or (iv) reckless disregard of the duties involved
in the conduct of such Indemnitee’s position (the conduct referred to in such clauses (i) through (iv) being sometimes
referred to herein as “disabling conduct”), (2) as to any matter disposed of by settlement or a compromise payment by such
Indemnitee, pursuant to a consent decree or otherwise, no indemnification either for said payment or for any other expenses shall be provided
unless there has been a determination that such settlement or compromise is in the best interests of the Trust and that such Indemnitee
appears to have acted in good faith in the reasonable belief that such Indemnitee’s action was in the best interest of the Trust
and did not involve disabling conduct by such Indemnitee and (3) with respect to any action, suit or other proceeding voluntarily
prosecuted by any Indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding
by such Indemnitee was authorized by a majority of the full Board of Trustees of the Trust.
(b) The
Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might
be sought hereunder if the Trust receives a written affirmation of the Indemnitee’s good faith belief that the standard of conduct
necessary for indemnification has been met and a written undertaking to reimburse the Trust unless it is subsequently determined that
such Indemnitee is entitled to such indemnification and if the trustees of the Trust determine that the facts then known to them would
not preclude indemnification. In addition, at least one of the following conditions must be met: (A) the Indemnitee shall provide
a security for such Indemnitee-undertaking, (B) the Trust shall be insured against losses arising by reason of any lawful advance,
or (C) a majority of a quorum consisting of trustees of the Trust who are neither “interested persons” of the Trust (as
defined in Section 2(a)(19) of the 1940 Act) nor parties to the proceeding (“Disinterested Non-Party Trustees”) or an independent
legal counsel in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full trial-type inquiry),
that there is reason to believe that the Indemnitee ultimately will be found entitled to indemnification.
(c) All determinations
with respect to indemnification hereunder shall be made (1) by a final decision on the merits by a court or other body before whom the
proceeding was brought that such Indemnitee is not liable or is not liable by reason of disabling conduct, or (2) in the absence of such
a decision, by (i) a majority vote of a quorum of the Disinterested Non-Party Trustees of the Trust, or (ii) if such a quorum is not obtainable
or, even if obtainable, if a majority vote of such quorum so directs, independent legal counsel in a written opinion. All determinations
that advance payments in connection with the expense of defending any proceeding shall be authorized shall be made in accordance with
the immediately preceding clause (2) above.
The rights accruing
to any Indemnitee under these provisions shall not exclude any other right to which such Indemnitee may be lawfully entitled.
Insofar as indemnification for liabilities arising
under the Securities Act of 1933, as amended, may be provided to trustees, officers and controlling persons of the Trust, pursuant to
the foregoing provisions or otherwise, the Trust has been advised that in the opinion of the Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act of 1933, as amended, and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the Trust of expenses incurred or paid by a trustee, officer
or controlling person of the Trust in connection with the successful defense of any action, suit or proceeding or payment pursuant to
any insurance policy) is asserted against the Trust by such trustee, officer or controlling person in connection with the securities being
registered, the Trust will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
| Item 31. | Business and Other Connections of Investment Advisor |
CBRE Investment Management Listed Real Assets
LLC (the “Advisor”), a limited liability company organized under the laws of the State of Delaware, serves as investment adviser
to the Registrant. The Registrant is fulfilling the requirement of this Item 31 by confirming that the Advisor, nor any officers or directors
of the Advisor, engaged in any other business, profession, vocation or employment of a substantial nature during the Registrant’s
past two fiscal years other than their positions with the Registrant. The positions of the officers and directors of the Advisor, held
with the Registrant, are disclosed in one or more of the following documents: (1) the Registrant’s Statement of Additional Information;
(2) the Registrant’s Annual Shareholder Report dated December 31, 2023; and (3) the Advisor’s Form ADV (File No. 801-49083)
filed under the Investment Advisers Act of 1940, as amended.
| Item 32. | Location of Accounts and Records |
The Registrant’s accounts, books and other
documents are currently located at the offices of the Registrant, c/o CBRE Investment Management Listed Real Assets LLC, 555 East Lancaster
Avenue, Suite 120, Radnor, Pennsylvania 19087, and at the offices of The Bank Of New York Mellon, the Registrant’s Custodian, Administrator,
and the Transfer Agent, located at 240 Greenwich Street, New York, New York 10286.
| Item 33. | Management Services |
Not Applicable.
1. Not applicable.
2. Not applicable.
3. The Registrant undertakes:
| (a) | to file, during a period in which offers or sales are being made, a post-effective amendment to this Registration
Statement: |
| (1) | to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended
(the “Securities Act”); |
| (2) | to reflect in the prospectus any facts or events after the effective date of the registration statement
(or the most recent post- effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the
information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if,
in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth
in the “Calculation of Registration Fee” table in the effective registration statement. |
| (3) | to include any material information with respect to the plan of distribution not previously disclosed
in the Registration Statement or any material change to such information in the Registration Statement. |
Provided, however, that
paragraphs (a)(1), (a)(2), and (a)(3) of this section do not apply to the extent the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13
or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference
into the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration
statement.
| (b) | that, for the purpose of determining any liability under the Securities Act, each post-effective amendment
to this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the
offering of those securities at that time shall be deemed to be the initial bona fide offering thereof; |
| (c) | to remove from registration by means of a post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering; |
| (d) | that, for the purpose of determining liability under the Securities Act to any purchaser: |
| (1) | if the Registrant is relying on Rule 430B [17 CFR 230.430B]: |
| (A) | Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration
statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
| (B) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration
statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi) for the purpose of providing
the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities
in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at
that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities
in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date; or |
| (2) | if the Registrant is subject to Rule 430C: each prospectus filed pursuant to Rule 424(b) under the Securities
Act as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than
prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it
is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus
that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede
or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made
in any such document immediately prior to such date of first use. |
| (e) | that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser
in the initial distribution of securities: |
The undersigned Registrant undertakes
that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to
the purchaser:
| (1) | any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required
to be filed pursuant to Rule 424 under the Securities Act; |
| (2) | free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant
or used or referred to by the undersigned Registrant; |
| (3) | the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities
Act relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf
of the undersigned Registrant; and |
| (4) | any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser. |
4. Not applicable.
5. The undersigned Registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant
to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference into the registration statement shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
6. Insofar as indemnification for liabilities
arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that in the opinion of the U.S. Securities and Exchange Commission such indemnification
is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
7. The Registrant undertakes to send by first
class mail or other means designed to ensure equally prompt delivery within two business days of receipt of a written or oral request,
any Statement of Additional Information.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933 and/or the Investment Company Act of 1940, the Registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Radnor, and Commonwealth of Pennsylvania, on the 13th day of September,
2024.
|
CBRE GLOBAL REAL ESTATE INCOME FUND |
|
|
|
/s/ Joseph P. Smith |
|
Joseph P. Smith |
|
President and Principal Executive Officer |
Pursuant to the requirements
of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the
dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ T. Ritson Ferguson* |
|
Member of the Board of Trustees |
|
September 13, 2024 |
T. Ritson Ferguson |
|
|
|
|
|
|
|
|
|
/s/ Asuka Nakahara* |
|
Member of the Board of Trustees |
|
September 13, 2024 |
Asuka Nakahara |
|
|
|
|
|
|
|
|
|
/s/ John R. Bartholdson* |
|
Member of the Board of Trustees |
|
September 13, 2024 |
John R. Bartholdson |
|
|
|
|
|
|
|
|
|
/s/ Leslie E. Greis* |
|
Member of the Board of Trustees |
|
September 13, 2024 |
Leslie E. Greis |
|
|
|
|
|
|
|
|
|
/s/ Heidi Stam* |
|
Member of the Board of Trustees |
|
September 13, 2024 |
Heidi Stam |
|
|
|
|
|
|
|
|
|
/s/ Peter Finnerty* |
|
Member of the Board of Trustees |
|
September 13, 2024 |
Peter Finnerty |
|
|
|
|
|
|
|
|
|
/s/ Jonathan A. Blome
|
|
Principal Financial Officer |
|
September 13, 2024 |
Jonathan A. Blome |
|
|
|
|
/s/ Joseph P. Smith |
|
* Joseph P. Smith, Attorney-in-Fact, pursuant to power of attorney |
EXHIBIT INDEX
Yes
false
POS EX
0001268884
0001268884
2024-09-13
2024-09-13
0001268884
dei:BusinessContactMember
2024-09-13
2024-09-13
Exhibit (h)(4)
DISTRIBUTION AGREEMENT
This DISTRIBUTION AGREEMENT
(this “Agreement”) made as of September 13, 2024 by and between CBRE Global Real Estate Income Fund, a Delaware statutory
trust (the “Fund”), and Foreside Fund Services, LLC, a Delaware limited liability company (the “Distributor”).
WITNESSETH:
WHEREAS, the Fund is
registered under the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (collectively, the “Investment
Company Act”), as a diversified, closed-end, management investment company;
WHEREAS, the Fund has
filed a registration statement on Form N-2 (File Nos. 333-269889 and 811-21465) pursuant to the Investment Company
Act and the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the “Securities Act”),
to register common shares of beneficial interest, $0.001 par value per share, of the Fund (the “Common Shares”), which
may be issued and sold from time to time through various specified transactions, including at-the-market (“ATM”)
offerings pursuant to Rule 415 under the Securities Act;
WHEREAS, the Distributor
is registered as a broker-dealer under the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations
thereunder (collectively, the “Exchange Act”), and is a member in good standing of the Financial Industry Regulatory
Authority, Inc. (“FINRA”); and
WHEREAS, the Fund and
the Distributor wish to enter into a distribution agreement with each other with respect to ATM offerings, from time to time, of Common
Shares.
NOW THEREFORE, the parties
agree as follows:
Section 1. Appointment
of the Distributor; ATM Offerings.
(a)
Subject to the terms and conditions of this Agreement, the Fund hereby appoints the Distributor as its principal underwriter and placement
agent for up to 40,000,000 Common Shares of the Fund to be offered pursuant to the Registration Statement (as defined herein) through
ATM offerings from time to time (the “Shares”) and the Fund agrees that it will issue such Shares as the Distributor
may sell. The Distributor agrees to enter into non-exclusive sub-placement agent agreements with selected dealers,
each of whom shall be registered as a broker-dealer under the provisions of the Exchange Act and a member in good standing of FINRA who
will use reasonable efforts to identify opportunities for the sale of Shares (each, a “sub-placement agent”),
but neither the Distributor nor any sub-placement agent is obligated to sell any specific number of the Shares (though
the Distributor will only be authorized to sell on any Offering Date, subject to the terms and conditions of this Agreement, the maximum
number of Shares agreed to with the Fund pursuant to Section 1(d) hereof). The Distributor will not purchase any Shares for its own
account. The Shares will only be sold on such days as shall be agreed to by the Distributor and the Fund (each, an “Offering
Date”). The Distributor hereby accepts such appointment.
(b) The
Distributor acknowledges that Shares will be offered and sold only as set forth from time to time in the Registration Statement including,
without limitation, pricing of Shares, handling of investor funds and payment of sales commissions.
(c) The
Fund may suspend or terminate any ATM offering of its Shares at any time. Upon notice to the Distributor of the terms of such suspension
or termination, the Distributor shall suspend the ATM offering of Shares in accordance with such terms until the Fund notifies the Distributor
that such ATM offering may be resumed; provided, however, that such suspension or termination shall not affect
or impair the parties’ respective obligations with respect to the Shares sold hereunder prior to the giving of such notice.
(d) The
price per Share shall be determined by the Fund together with the Distributor or any sub-placement agent by reference to
trades in the Common Shares on the primary exchange for the Common Shares. In no event shall the price per Share be less than the then
current net asset value per Common Share (which net asset value shall be determined as of a time within twenty-four (24) hours, excluding
Saturdays, Sundays and holidays, next preceding the time of such determination) plus the per Share amount of the commission to be paid
to the Distributor (the “Minimum Price”). The Fund may establish a minimum sales price per Share on any Offering Date
in excess of the Minimum Price (the “Minimum Sales Price”), and the Fund shall communicate such Minimum Sales Price
to the Distributor. The Fund shall have sole discretion to establish a Minimum Sales Price for any Offering Date. The Distributor agrees
that it will not sell Shares if the per share price of the Shares is less than the Minimum Price or, if applicable, the Minimum Sales
Price. The Fund shall determine the maximum number of Shares to be sold through the Distributor or through such sub-placement agent for
any Offering Date, and the Distributor or such sub-placement agent shall not be authorized to sell Shares on any Offering
Date in excess of such maximum.
(e) The
Distributor will confirm to the Fund, following the close of trading on the Fund’s primary exchange on each Offering Date for the
Shares, the number of Shares sold through the Distributor and through any sub-placement agent, the time of sale, the
gross sales price per Share and the compensation payable to the Distributor and such sub-placement agent, or to which the Distributor
and such sub-placement agent are entitled with respect to such sales. The Fund reserves the right to reject any order
in whole or in part.
(f) Settlement
for sales of the Shares pursuant to this Section 1 will occur on the business day following the date on which such sales are made
(each such day, a “Settlement Date”), unless otherwise agreed to in writing by the parties hereto. On each Settlement
Date, the Shares sold through the Distributor and through any sub-placement agent for settlement on such date shall
be delivered by the Fund at the Distributor’s request to such sub-placement agent’s account at The Depository Trust
Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the
parties, against payment of the gross sales proceeds for the sale of such Shares, less the sales commission to be paid to the Distributor.
(g) In
selling Shares, the Distributor shall act solely as an agent of the Fund and not as principal.
Section 2. Representations
and Warranties by the Fund. The Fund represents, warrants to and agrees with the Distributor, as of the date hereof and as of each
Offering Date and Settlement Date, that:
(a) The
Registration Statement (i) is an “automatic shelf registration statement” as defined in Rule 405 under the Securities
Act; (ii) has been prepared by the Fund in conformity with the requirements of the Securities Act and the Investment Company Act
in all material respects; and (iii) has been filed with the U.S. Securities and Exchange Commission (the “Commission”)
under the Securities Act and the Investment Company Act; the Registration Statement sets forth the terms of the offering, sale and plan
of distribution of the Shares and contains additional information concerning the Fund and its business; no notice of objection of the
Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities
Act has been received by the Fund; the Registration Statement, including any amendments thereto, became effective upon filing; no stop
order of the Commission preventing or suspending the use of the Base Prospectus (as defined herein), the Prospectus Supplement (as defined
herein) or the Prospectus (as defined herein), or the effectiveness of the Registration Statement, has been issued, and no proceedings
for such purpose have been instituted or, to the Fund’s knowledge, have been threatened by the Commission. Except where the context
otherwise requires, “Registration Statement,” as used herein, means, collectively, the various parts of the registration
statement, as amended at the time of effectiveness for purposes of Section 11 of the Securities Act (the “Effective Time”),
as such section applies to the Distributor, as well as any new registration statement, post-effective amendment or new shelf registration
statement relating to the Shares, including (1) all documents filed as a part thereof or incorporated or deemed to be incorporated
by reference therein, (2) any information contained or incorporated by reference in a prospectus filed with the Commission pursuant
to Rule 424(b) under the Securities Act, to the extent such information is deemed, pursuant to Rule 430B or Rule 430C under
the Securities Act, to be part of the registration statement at the time of such registration statement’s effectiveness for purposes
of Section 11 of the Securities Act, as such section applies to the Distributor, and (3) any registration statement filed to
register the offer and sale of Shares pursuant to Rule 462(b) under the Securities Act. “Base Prospectus,” as
used herein, means the final prospectus filed as part of the Registration Statement, including the related statement of additional information,
together with any amendments or supplements thereto as of the date of this Agreement. Except where the context otherwise requires, “Prospectus
Supplement,” as used herein, means the final prospectus supplement, including the related statement of additional information,
relating to the Shares, filed by the Fund with the Commission pursuant to Rule 424(b) under the Securities Act, in the form furnished
by the Fund to the Distributor in connection with the offering of the Shares. Except where the context otherwise requires, “Prospectus,”
as used herein, means the Prospectus Supplement together with the Base Prospectus attached to or used with the Prospectus Supplement.
Any reference herein to the Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus shall be deemed to
refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by reference, therein.
(b) The
Fund is duly registered under the Investment Company Act as a closed-end management investment company. A
notification of registration of the Fund as an investment company under the Investment Company Act
on Form N-8A (the “Investment Company Act Notification”) has been prepared by the Fund in
conformity with the Investment Company Act and has been filed with the Commission and, at the time of filing thereof and at the time
of filing any amendment or supplement thereto, conformed in all material respects with all applicable provisions of the Investment
Company Act. The Fund has not received any notice in writing from the Commission pursuant to Section 8(e) of the Investment
Company Act with respect to the Investment Company Act Notification or the Registration Statement (or any amendment or supplement to
either of them). No person is serving or acting as an officer, trustee or investment adviser of the Fund except in accordance with
the provisions of the Investment Company Act, provided that for purposes of the foregoing representation with respect to officers
and trustees, the Fund shall be entitled to rely on representations from such officers and trustees.
(c) The
Registration Statement, the Investment Company Act Notification and the Prospectus, as from time to time amended or supplemented, each
complied when it became effective or was filed (as the case may be), complies as of the date hereof and, as amended or supplemented, will
comply, at each time of purchase of Shares in connection with the ATM offerings, and at all times during which a prospectus is required
by the Securities Act to be delivered in connection with any sale of Shares, in all material respects, with the requirements of the Securities
Act and the Investment Company Act; the Registration Statement did not, as of the Effective Time, contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; at no
time during the period that begins on the earlier of the date of the Base Prospectus or the date the Base Prospectus was filed with the
Commission and ends at the later of the time of purchase of Shares in connection with the ATM offerings or the end of the period during
which a prospectus is required by the Securities Act to be delivered in connection with any sale of Shares did or will the Prospectus,
as from time to time amended or supplemented, include an untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however,
that the Fund does not make any representation or warranty with respect to any statement contained in the Registration Statement, the
Base Prospectus or the Prospectus in reliance upon and in conformity with information furnished in writing by the Distributor or any sub-placement agents, or
on the Distributor’s or any sub-placement agent’s behalf, to the Fund expressly for use in the Registration Statement
or the Prospectus (the “Agent Provided Information”).
(d) The
financial statements incorporated by reference in the Registration Statement or the Prospectus, together with the related notes and
schedules, (i) present fairly in all material respects the financial position of the Fund as of the dates indicated and the
results of operations, cash flows and changes in shareholders’ equity of the Fund for the periods specified and (ii) have
been prepared in compliance in all material respects with the requirements of the Securities Act, the Investment Company Act and the
Exchange Act, and in conformity in all material respects with U.S. generally accepted accounting principles applied on a consistent
basis during the periods involved; the other financial and statistical data contained or incorporated by reference in the
Registration Statement or the Prospectus are accurately and fairly presented, in all material respects, and prepared on a basis
consistent with the financial statements and books and records of the Fund in all material respects; there are no financial
statements that are required to be included or incorporated by reference in the Registration Statement, the Base Prospectus or the
Prospectus by the Securities Act, the Investment Company Act or the Exchange Act that are not included or incorporated by reference
as required; and the Fund does not have any material liabilities or obligations, direct or contingent
(including any off-balance sheet obligations), not described in the Registration Statement (excluding the
exhibits thereto).
(e) As
of the date of this Agreement, the Fund has an authorized and outstanding capitalization as set forth in the Registration Statement, the
Base Prospectus and the Prospectus and, with respect to any issuance and sale under this Agreement, the Fund shall have as of the date
of the most recent amendment or supplement to the Registration Statement or Prospectus, an authorized and outstanding capitalization as
set forth in the Registration Statement and the Prospectus; all of the issued and outstanding Common Shares have been duly authorized
and validly issued and are fully paid and non-assessable, have been issued in material compliance with all applicable
securities laws and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right.
(f) The
Fund has been duly formed, has legal existence as a statutory trust and is in good standing under the laws of Delaware, with full power
and authority to own, lease and operate and conduct its business as described in the Registration Statement, the Base Prospectus and the
Prospectus and to issue, sell and deliver the Shares as contemplated herein. The Fund is duly qualified to do business as a foreign entity
and is in good standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to
be so qualified and in good standing would not, individually or in the aggregate, have a material adverse effect on the business, properties,
financial condition or results of operations of the Fund.
(g) The
Shares have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, will be duly
and validly issued, fully paid and non-assessable and free of statutory and contractual preemptive rights, resale
rights, rights of first refusal and similar rights; the Shares, when issued and delivered against payment therefor as provided herein,
will be free of any restriction upon the voting or transfer thereof pursuant to the Fund’s Amended and Restated Agreement and Declaration
of Trust, as further amended or supplemented, the Fund’s Amended and Restated By-Laws, as further amended or supplemented, or any
agreement or other instrument to which the Fund is a party. The Common Shares, including the Shares, conform in all material respects
to the description thereof, if any, contained or incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus;
and the certificates for the Shares, if any, are in due and proper form.
(h) The
Fund is in material compliance with the rules of the New York Stock Exchange (the “Stock Exchange”), including, without
limitation, the requirements for continued listing of the Shares on the Stock Exchange and the Fund has not received any written notice
from the Stock Exchange regarding the delisting of the Shares from the Stock Exchange. The Shares will be duly listed, and admitted and
authorized for trading, subject to official notice of issuance, on the Stock Exchange.
(i) No
approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory
commission, board, body, authority or agency, or of or with any self-regulatory organization
or other non-governmental regulatory authority (including, without limitation, the Stock Exchange), or approval
of the shareholders of the Fund that has not already been obtained, is required in connection with the issuance and sale of the
Shares or the consummation by the Fund of the transactions contemplated hereby, other than (i) the registration of the Shares
under the Securities Act, which has been effected, (ii) the listing of the Shares with the Stock Exchange, upon official notice
of issuance, (iii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which the
Shares are being offered by the Fund or (iv) any necessary qualification pursuant to the rules of FINRA.
(j) Prior
to the execution of this Agreement, the Fund has not, directly or indirectly, offered or sold any Shares by means of any “prospectus”
or “free writing prospectus” (in each case within the meaning of the Securities Act) or used any “prospectus”
or “free writing prospectus” (in each case within the meaning of the Securities Act) in connection with the offer or sale
of the Shares, and from and after the execution of this Agreement, the Fund will not, directly or indirectly, offer or sell any Shares
by means of any “prospectus” or “free writing prospectus” (in each case within the meaning of the Securities Act)
or use any “prospectus” or “free writing prospectus” (in each case within the meaning of the Securities Act) in
connection with the offer or sale of the Shares, other than the Prospectus, as amended or supplemented from time to time in accordance
with the provisions of this Agreement; and the Fund is not an “ineligible issuer” (as defined in Rule 405 under the Securities
Act) as of the eligibility determination date for purposes of Rules 164 and 433 under the Securities Act with respect to the offering
of the Shares contemplated by the Registration Statement.
Section 3. Duties
of the Fund.
(a) The
Fund shall take, from time to time, but subject always to any necessary approval of the board of trustees of the Fund (the “Board”)
or of its shareholders, all necessary action to fix the number of authorized Common Shares, to the end that the Fund will have a number
of authorized but unissued Common Shares at least equal to the number of Common Shares available for sale pursuant to this Agreement.
(b) For
purposes of the ATM offering of Shares, the Fund will furnish to the Distributor and any sub-placement agents copies
of its most recent amendment to its Registration Statement, its most recent Prospectus and all amendments and supplements thereto, and
other documentation the Distributor may reasonably request for use in the ATM offering of Shares, including without limitation, and to
the extent applicable, a 415 No Objections Letter from FINRA. The Distributor and the sub-placement agents are authorized
to furnish to prospective investors only such information concerning the Fund and the ATM offering as may be contained in the Registration
Statement, the Prospectus, the Fund’s publicly available formation documents, or any other documents (including sales material),
that are expressly approved by the Fund for such purpose.
(c) The
Fund shall furnish to the Distributor copies of all financial statements of the Fund which the Distributor may reasonably request for
use in connection with its duties hereunder, and this shall include, upon request by the Distributor, one certified copy of all financial
statements prepared for the Fund by independent public accountants.
(d) The
Fund shall use its best efforts to qualify and maintain, to the extent required by applicable law, the qualification of Shares for
sale under the securities laws of such jurisdictions as the Distributor and the Fund may approve, provided that the Fund shall not
be required in connection therewith to qualify as a foreign corporation or dealer in securities or to file a general consent to
service of process in any jurisdiction or meet any other requirement in connection with this Section 3(d) deemed by the Fund to
be unduly burdensome. Any such qualification may be withheld, terminated or withdrawn by the Fund at any time in its discretion. The
expense of qualification and maintenance of qualification shall be borne by the Fund. The Distributor shall furnish such information
and other material relating to its affairs and activities as may be required by the Fund in connection with such qualification.
(e) The
Fund will furnish, in reasonable quantities upon request by the Distributor, copies of its annual and semi-annual reports.
(f) The
Fund will furnish the Distributor with such other documents as it may reasonably require, from time to time, for the purpose of enabling
it to perform its duties as contemplated by this Agreement.
Section 4. Duties
of the Distributor.
(a) The
Distributor shall use its reasonable best efforts to perform its duties hereunder. The services of the Distributor to the Fund hereunder
are not to be deemed exclusive and nothing herein contained shall prevent the Distributor from entering into like arrangements with other
investment companies so long as the performance of its obligations with respect to the Fund hereunder is not impaired thereby.
(b) In
performing its duties hereunder, the Distributor shall comply in all material respects with the requirements of all applicable laws, including
securities laws relating to the ATM offerings of Shares. Neither the Distributor nor any sub-placement agent having
an agreement to offer and sell Shares pursuant to Section 5 hereof nor any other person is authorized by the Fund to give any information
or to make any representations, other than those contained in its Registration Statement, Prospectus and any sales literature specifically
approved for such use by the Fund.
(c) The
Distributor or any sub-placement agent shall review and file with FINRA as applicable, all sales literature (advertisements,
brochures and shareholder communications) prepared in connection with the ATM offerings for the Fund.
(d) The
Distributor agrees to supply the following additional services, together with such other services as set forth throughout this Agreement:
|
1. |
handling inquiries from sub-placement agents regarding the Fund; |
|
2. |
assisting in the enhancement of communications between sub-placement agents and the Fund; |
|
3. |
communicating the Minimum Price or Minimum Sales Price to any sub-placement agents and instructing any sub-placement agents not to sell Shares if such sales cannot be effected at or above the Minimum Price or the Minimum Sales Price; |
|
4. |
communicating the maximum amount of Shares to be sold on any Offering Date and any other Fund instructions to any sub-placement agents; |
|
5. |
notifying any sub-placement agents of any suspension or termination of the ATM offering of Shares, together with any corresponding resumption of the ATM offering of Shares; |
|
6. |
coordinating delivery of any Shares sold through sub-placement agents to such sub-placement agents on the Settlement Date against payment of the gross sales proceeds for the sale of such Shares, less any applicable sub-placement agent selling commission; |
|
7. |
delivering the Fund’s Prospectus to any sub-placement agents; |
|
8. |
identifying potential sub-placement agents; |
|
9. |
monitoring the performance of sub-placement agents; |
|
10. |
providing any necessary reconciliation, accounting and recordkeeping services in respect of the ATM offerings of Shares, including with respect to the underwriting compensation paid by the Fund to the Distributor in respect thereof; and |
|
11. |
providing such other information, assistance and services as may be reasonably requested by the Fund. |
(e) The
Distributor shall report to the Board at least quarterly, or more frequently, as requested by the Board, regarding: (i) the
nature of the services provided by the Distributor hereunder; (ii) the amount
of compensation sub-placement agents, if any, are entitled to retain or be paid by the Distributor; and
(iii) the aggregate amount of underwriting compensation paid by the Fund to the Distributor in respect of the ATM offerings of
Shares.
(f) The
Distributor represents and warrants to the Fund that it has all necessary licenses to perform the services contemplated hereunder and
will perform such services in compliance with all applicable rules and regulations.
Section 5. Agreements with Sub-Placement Agents.
(a) The
Distributor may enter into sub-placement agent agreements or selected dealer agreements, on such terms and
conditions as the Distributor determines are not inconsistent with this Agreement, with sub-placement agents to act as the
Distributor’s agents to effect the sale of the Shares in the ATM offerings, and the Distributor will terminate one or more of
its sub-placement agent agreements or selected dealer agreements, to the extent instructed by the
Fund. Such sub-placement agents shall sell Shares only at market prices subject to the Minimum Price and the
Minimum Sales Price. This Agreement shall not be construed as authorizing any dealer or other person to accept orders for sale on
the Fund’s behalf or to otherwise act as the Fund’s agent for any purpose. The Distributor shall not be responsible for
the acts of other dealers or agents except as and to the extent that they shall be acting for the Distributor or under the
Distributor’s direction or authority.
(b) The
Distributor shall offer and sell Shares only through such sub-placement agents who are acting as brokers or dealers who are
registered as broker-dealers under the provisions of the Exchange Act and members in good standing of FINRA and who agree to abide by
the rules of FINRA.
(c) The
Distributor shall obtain assurance, reasonably satisfactory to the Fund, from any sub-placement agents which it engages of the
compliance by such sub-placement agents with the terms of this Agreement, applicable federal and state securities
laws and the rules of FINRA.
Section 6. Sales
Commission; Compensation.
(a) The
Fund shall pay the Distributor an amount equal to 1.00% of the gross sales price per Share of the Shares sold.
(b) The
Distributor shall pay to the sub-placement agents the sub-placement agent commissions agreed to between the Distributor
and such sub-placement agents, or may authorize such sub-placement agents to retain such sub-placement agent commissions
from the gross sales proceeds from the sale of such Shares, which shall be payable from the commissions payable to the Distributor under
Section 6(a) hereof; provided that the Distributor will not pay to the sub-placement agents compensation in excess of the usual and
customary distributor’s or selling agent’s commission in the ATM offerings of Shares.
(c) The
Fund hereby represents and warrants to the Distributor that (i) the terms of this Agreement, (ii) the fees and expenses associated
with this Agreement, and (iii) any benefits accruing to the Distributor or to the Fund’s investment adviser or sponsor or another
affiliate of the Fund in connection with this Agreement, which the Fund has agreed to pay, including but not limited to any fee waivers,
conversion cost reimbursements, up-front payments, signing payments or periodic payments relating to this Agreement
have been fully disclosed to the Board and that, if required by applicable law, the Board has approved or will approve the terms of this
Agreement, any such fees and expenses, and any such benefits.
Section 7. Payment
of Expenses.
(a) The
Fund shall bear all of its own costs and expenses, including fees and disbursements of its counsel and auditors, in connection with the
preparation of its Prospectus, Statement of Additional Information, if any, the preparation and filing of any required registration statements
under the Securities Act and/or the Investment Company Act, and all amendments and supplements thereto, and in connection with any fees
and expenses incurred with respect to any filing requirements of FINRA and preparing and mailing annual and interim reports and proxy
materials to shareholders (including but not limited to the expense of setting in type any such Registration Statement, Prospectus, interim
reports or proxy materials).
(b) The
Fund shall bear any cost and expenses of qualification of the Shares for sale pursuant to this Agreement.
(c) The
Distributor shall bear all expenses incurred by it in connection with its duties and activities under this Agreement, including the compensation of sub-placement agents for
sales of the Shares, provided that it shall pay such sub-placement agents only for so long as and to the extent that
it receives such compensation from the Fund, and fees and expenses of Distributor’s counsel (except for any FINRA filing fees or
“blue sky” fees paid on behalf of the Fund or the Distributor by such counsel).
Section 8. Limitation
of Liability; Indemnification.
(a) The
Distributor shall not be liable for any error of judgment or mistake of law or for any loss suffered by the Fund in connection with the
matters to which this Agreement relates, except a loss resulting from willful misfeasance, bad faith or gross negligence on its part in
the performance of its duties or from material breach or reckless disregard by it of its obligations and duties under this Agreement.
The Distributor shall not be liable for any damages arising out of any action or omission to act by any prior service provider of the
Fund or for any failure to discover any such error or omission (provided that this sentence shall not apply where the Distributor was
the prior service provider). Notwithstanding anything in this Agreement to the contrary, the Distributor shall not be liable for damages
occurring directly or indirectly by reason of circumstances beyond its reasonable control.
(b) The
Fund agrees that it will indemnify, defend and hold harmless the Distributor, its several officers and directors, and any person who controls
the Distributor within the meaning of Section 15 of the Securities Act, from and against any losses, claims, damages or liabilities,
joint or several, to which the Distributor, its several officers and directors, and any person who controls the Distributor within the
meaning of Section 15 of the Securities Act, may become subject under the Securities Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions or proceedings in respect thereof) (i) arise out of, or are based upon any untrue statement or
alleged untrue statement of a material fact contained in the Registration Statement, the Prospectuses or in any application or other document
executed by or on behalf of the Fund or are based upon information furnished by or on behalf of the Fund filed in any state in order to
qualify the Shares under the securities or blue sky laws thereof (“Blue Sky Application”) or arise out of, or are based
upon, the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading; or (ii) arise out of, or are based upon, any material breach of the representations, warranties or covenants
of the Fund contained in this Agreement; provided, however, that the Fund shall not be liable in any case to the
extent that such loss, claim, damage or liability arises out of, or is based upon, any untrue statement, alleged untrue statement, or
omission or alleged omission made in the Registration Statement, the Prospectus or any Blue Sky Application with respect to the Fund in
reliance upon and in conformity with any Agent Provided Information, or arising out of the failure of the Distributor or any sub-placement agent to
deliver a current Prospectus. Notwithstanding anything in this Agreement to the contrary, the Fund shall not be liable for damages occurring
directly or indirectly by reason of circumstances beyond its reasonable control.
(c) The
Distributor will indemnify, defend and hold harmless the Fund, its several officers and trustees, and any person who controls the Fund
within the meaning of Section 15 of the Securities Act, from and against any losses, claims, damages or liabilities, joint or several,
to which any of them may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions or proceedings in respect thereof) arise out of, or are based upon, any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement, the Prospectus or any Blue Sky Application, or arise out of, or are based upon,
the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein
not misleading, which statement or omission was made in reliance upon and in conformity with information furnished in writing to the Fund
or any of its several officers by or on behalf of the Distributor specifically for inclusion therein, and will reimburse the Fund, its
several officers and trustees, and such controlling persons for any legal or other expenses reasonably incurred by any of them in investigating,
defending or preparing to defend any such action, proceeding or claim.
(d) An
indemnified person under this Section 8 (the “Indemnified Party”) shall give written notice to the other party
(the “Indemnifying Party”) of any loss, damage, expense, liability or claim in respect of which the Indemnifying Party
has a duty to indemnify such Indemnified Party under Section 8(b) or (c) hereof (a “Claim”), specifying in
reasonable detail the nature of the loss, damage, expense, liability or claim for which indemnification is sought, except that any delay
or failure so to notify such Indemnifying Party shall only relieve such Indemnifying Party of its obligations hereunder to the extent,
if at all, that such Indemnifying Party is actually prejudiced by reason of such delay or failure.
(e) If
a Claim results from any action, suit or proceeding brought or asserted against an Indemnified Party, the Indemnifying Party shall
assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of
all fees and expenses. The Indemnified Party shall have the right to employ separate counsel in such action, suit or proceeding and
participate in such defense thereof, but the fees and expenses of such separate counsel shall be at the expense of the Indemnified
Party unless (i) the Indemnifying Party has agreed in writing to pay such fees and expenses, (ii) the Indemnifying Party
has failed within a reasonable time to assume the defense and employ counsel or (iii) the named parties to any such action,
suit or proceeding (including any impleaded parties) include both such Indemnified Party and Indemnifying Party and such Indemnified
Party shall have been advised by its counsel that representation of such Indemnified Party and Indemnifying Party by the same
counsel would be inappropriate under applicable standards of professional conduct (whether or not such representation by the same
counsel has been proposed) due to actual or potential differing interests between the Indemnifying Party and the Indemnified Party
(in which case the Indemnifying Party shall not have the right to assume the defense of such action, suit or proceeding on behalf of
such Indemnified Party). It is understood, however, that the Indemnifying Party shall, in connection with any one action, suit or
proceeding or separate but substantially similar or related actions, suits or proceedings in the same jurisdiction arising out of
the same general allegations or circumstances be liable for the reasonable fees and expenses of only one separate firm of attorneys
(in addition to any local counsel) at any time for all such Indemnified Parties not having actual or potential differing interests
with the Indemnifying Party or among themselves, which firm shall be designated in writing by an authorized representative of such
parties and that all such fees and expenses shall be reimbursed promptly as they are incurred. The Indemnifying Party shall not be
liable for any settlement of any such action, suit or proceeding effected without its written consent, but if settled with such
written consent or if there be a final judgment for the plaintiff in any such action, suit or proceeding, the Indemnifying Party
agrees to indemnify and hold harmless any Indemnified Party from and against any loss, liability, damage or expense by reason by
such settlement or judgment.
(f) With
respect to any Claim not within Section 8(e) hereof, the Indemnifying Party shall have twenty (20) days from receipt of notice
from the Indemnified Party of such Claim within which to respond thereto. If the Indemnifying Party does not respond within such twenty-day period, it
shall be deemed to have accepted responsibility to make payment and shall have no further right to contest the validity of such Claim.
If the Indemnifying Party notifies the Indemnified Party within such twenty-day period that it rejects such Claim
in whole or in part, the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party under applicable
law.
(g) If
the indemnification provided for in this Section 8 is unavailable to an Indemnified Party or insufficient to hold an Indemnified
Party harmless in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable Indemnifying
Party shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, damages, expenses, liabilities
or claims in such proportion as is appropriate to reflect (i) the relative benefits received by the Indemnified Party, on the one
hand, and the Indemnifying Party, on the other hand, from the offering of the Shares; or (ii) if, but only if, the allocation provided
for in clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
referred to in clause (i) but also the relative fault of the Indemnified Party, on the one hand, and of the Indemnifying Party, on
the other, in connection with any statements or omissions or other matters which resulted in such losses, damages, expenses, liabilities
or claims, as well as any other relevant equitable considerations. The relative fault of the parties hereto shall be determined by reference
to, among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates
to information supplied by such party, on one hand, or by the other party, on the other hand, and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission. The amount paid or payable by a party
hereto as a result of the losses, damages, expenses, liabilities and claims referred to in this subsection shall be deemed to include
any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending
any proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 8 were
determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred
to in this Section 8(g). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
(h) Notwithstanding
any other provisions in this Section 8, no party shall be entitled to indemnification or contribution under this Agreement against
any loss, claim, liability, expense or damage arising by reason of such person’s willful misfeasance, bad faith or gross negligence
in the performance of its duties hereunder or by reason of such person’s material breach or reckless disregard of such person’s
obligations and duties thereunder.
(i) The
indemnity and contribution agreements contained in this Section 8 and the covenants, warranties and representations of the parties
contained in this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Fund, its
trustees or officers, or any person (including each officer or trustee of such person) who controls the Fund within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act, or by or on behalf of the Distributor, its directors or officers, or any
person who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act,
and shall survive any termination of this Agreement or the issuance and delivery of the Shares.
(j) IN
NO EVENT WILL ANY PARTY TO THIS AGREEMENT BE LIABLE TO ANY OTHER PERSON OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL
OR INDIRECT DAMAGES (INCLUDING BUT NOT LIMITED TO LOST PROFITS), EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES.
Section 9. Duration
and Termination of this Agreement.
(a) This
Agreement may be terminated at any time, without the payment of any penalty, by the Fund or by the Distributor, on sixty (60) days’
written notice to the other party.
(b) Unless
earlier terminated pursuant to Section 9(a) hereof, this Agreement shall automatically terminate upon the issuance and sale of all of
the Shares through the Distributor or any sub-placement agents on the terms and subject to the conditions set forth herein.
(c) This
Agreement shall remain in full force and effect unless terminated pursuant to Sections 9(a) or 9(b) hereof.
(d) Any
termination of this Agreement shall be effective on the date specified in such notice of termination; provided that such termination shall
not be effective until the close of business on the date of receipt of such notice by the other party. If such termination shall occur
prior to the Settlement Date for any sale of Shares, such Shares shall settle in accordance with the provisions of this Agreement.
Section 10. Amendments
of this Agreement. This Agreement may be amended by the parties only pursuant to a written instrument executed by the Fund and the
Distributor.
Section 11. Governing
Law. This Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of or in any way relating
to this Agreement, directly or indirectly, shall be governed by, and construed in accordance with, the internal laws of the State of New
York. To the extent that the applicable law of the State of New York, or any of the provisions herein, conflict with the applicable provisions
of the Investment Company Act, the latter shall control.
Section 12. Waiver
of Jury Trial. EACH OF THE FUND (ON ITS BEHALF AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS AFFILIATES) AND
THE DISTRIBUTOR (ON ITS BEHALF AND, TO THE EXTENT PERMITTED BY APPLICABLE LAW, ON BEHALF OF ITS MEMBERS AND AFFILIATES) WAIVES ALL
RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) IN ANY WAY ARISING
OUT OF OR RELATING TO THIS AGREEMENT.
Section 13. Miscellaneous.
(a) The
captions in this Agreement are included for convenience of reference only and in no way define or delimit any of the provisions hereof
or otherwise affect their construction or effect.
(b) This
Agreement constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written
and oral, among the parties hereto with regard to the subject matter hereof. If any provision of this Agreement shall be held or made
invalid by a court decision, statute, rule or otherwise, the remainder of this Agreement shall not be affected thereby.
(c) This
Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns
and the officers, directors, trustees and controlling persons referred to in Section 8 hereof. Neither party may assign its rights
or obligations under this Agreement without the prior written consent of the other party.
(d) The
parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any stock
split, stock dividend or similar event effected with respect to the Shares.
(e) The
terms “affiliated person” and “interested person,” when used in this Agreement, shall have the respective meanings
specified in the Investment Company Act.
Section 14. Proprietary
and Confidential Information. The Distributor agrees on behalf of itself and its employees to treat confidentially and as proprietary
information of the Fund all records and other information relative to the Fund and prior, present or potential shareholders, and not to
use such records and information for any purpose other than performance of its responsibilities and duties hereunder, except after prior
notification to and approval in writing by the Fund, which approval shall not be required where the Distributor may be exposed to civil
or criminal contempt proceedings for failure to comply, when requested to divulge such information by duly constituted authorities, or
when so requested by the Fund. The provisions of this Section 14 shall survive termination of this Agreement.
Notwithstanding anything
in this Agreement to the contrary, each party hereto agrees that: (i) any Nonpublic Personal Information, as defined under Section 248.3(t)
of Regulation S-P (“Regulation S-P”), promulgated under the Gramm-Leach-Bliley Act (the “Act”),
disclosed by a party hereunder is for the specific purpose of permitting the other party to perform the services set forth in this Agreement,
and (ii) with respect to such information, each party will comply with Regulation S-P and the Act and will not
disclose any Nonpublic Personal Information received in connection with this Agreement to any other party, except to the extent as necessary
to carry out the services set forth in this Agreement or as otherwise permitted by Regulation S-P or the Act.
Section 15. Notices.
All communications hereunder will be in writing and effective only on receipt, and will be mailed, delivered or emailed and confirmed
to:
If to the Distributor:
Foreside Fund Services,
LLC
Three Canal Plaza, Suite 100
Portland, Maine 04101
Attention: Legal Department
Email: legal@foreside.com
For all operational notices
or communications: etp-services@foreside.com
If to the Fund:
CBRE Global Real Estate
Income Fund
555 East Lancaster Avenue,
Suite 120
Radnor, Pennsylvania
19087
Attention: Jonathan
Blome, Principal Financial Officer
Email: Jonathan.Blome@cbreim.com
[The remainder of this
page is intentionally left blank]
IN WITNESS WHEREOF, the
parties hereto have executed this Agreement as of the day and year first above written. This Agreement may be executed by the parties
hereto in any number of counterparts, all of which shall constitute one and the same instrument.
|
CBRE GLOBAL REAL ESTATE INCOME FUND |
|
|
|
|
By: |
/s/ Joseph P. Smith |
|
Name: |
Joseph P. Smith |
|
Title: |
President and Principal Executive Officer |
|
|
|
FORESIDE FUND SERVICES, LLC |
|
|
|
|
By: |
/s/ Teresa Cowan |
|
Name: |
Teresa Cowan |
|
Title: |
President |
Exhibit (h)(5)
SUB-PLACEMENT AGENT AGREEMENT
Foreside Fund Services,
LLC
Three Canal Plaza,
Suite 100
Portland, Maine 04101
September 13, 2024
UBS Securities LLC
1285 Avenue of the Americas
New York, New York 10019
| RE: | At-the-Market Offerings by CBRE Global Real Estate Income
Fund |
Ladies and Gentlemen:
From time to time Foreside
Fund Services, LLC (the “Distributor,” “we” or “us”) will act as manager of registered at-the-market offerings by
CBRE Global Real Estate Income Fund, a Delaware statutory trust (the “Fund”), of up to 40,000,000 common shares (the
“Shares”) of beneficial interest, $0.001 par value per share, of the Fund (the “Common Shares”).
In the case of such offerings, the Fund has agreed with the Distributor to issue and sell through the Distributor, as sales agent, the
Shares (the “Distribution Agreement”).
We hereby agree to retain
UBS Securities LLC (the “Agent” or “you”) as a sub-placement agent with respect
to the offerings of the Shares to be issued and sold by the Fund (the “Offerings”) as the Fund and the Distributor
may indicate from time to time, and you agree to act in such capacity, all upon, and subject to, the terms and conditions set forth below:
SECTION 1. Description
of Offerings.
(a) The
Shares are to be sold on a daily basis or otherwise as shall be determined by the Fund together with the Distributor or the Agent on any
day (each, an “Offering Date”) that is a trading day for the exchange on which the Shares are listed and primarily
trade (the “Stock Exchange”) (other than a day on which the Stock Exchange is scheduled to close prior to its regular
weekday closing time). Promptly after the Fund has determined the maximum amount of the Shares to be distributed by the Distributor for
any Offering Date, which shall not in any event exceed the amount available for issuance under the currently effective Registration Statement
(as defined herein) (the “Maximum Daily Amount”), and the Minimum Daily Price (as defined herein), the Distributor
shall advise the Agent of the Maximum Daily Amount and the Minimum Daily Price. Subject to the terms and conditions herein, the Agent
shall use its reasonable best efforts to sell all of the Shares designated in accordance with the plan of distribution set forth in the
Prospectus Supplement (as defined herein); provided, however, that in no event shall the Agent sell Shares in excess of the Maximum Daily
Amount or for a price per Share below the Minimum Daily Price. The gross sales price of the Shares sold under this Section 1(a) shall
be the market price at which the Agent sells such Shares. The “Minimum Daily Price” means the minimum price per Share
below which the Shares may not be sold by the Agent on any Offering Date, which shall not in any event be less than the current net asset
value of such Shares (which net asset value shall be determined as of a time within twenty-four (24) hours, excluding Saturdays,
Sundays and holidays, next preceding the time of such determination), plus the per Share amount of the commission to be paid to the Distributor.
(b) Notwithstanding
the foregoing, the Distributor or the Fund may instruct the Agent by telephone (confirmed promptly by e-mail or other
electronic means) of a revised Minimum Daily Price and/or a revised Maximum Daily Amount and the Agent shall not sell Shares for a price
per Share below such revised Minimum Daily Price, or in a quantity in excess of such revised Maximum Daily Amount, after the giving of
such notice. In addition, the Fund, or the Distributor in consultation with the Fund, may, upon notice to the Agent by telephone (confirmed
promptly by e-mail or other electronic means), suspend the offering of the Shares at any time; provided, however,
that such suspension or termination shall not affect or impair the parties’ respective obligations with respect to the Shares sold
hereunder prior to the giving of such notice.
(c) The
Agent agrees not to make any sales of the Shares pursuant to this Section 1, other than through transactions for which compliance
with Rule 153 under the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the “Securities
Act”), will satisfy the prospectus delivery requirements of Section 5(b)(2) of the Securities Act.
(d) The
compensation to the Agent, as a sub-placement agent for each sale of the Shares pursuant to this Section 1, shall
be the Applicable Selling Agent Commission (as set forth on the Addendum hereto) with respect to the Shares sold, multiplied by the Gross
Sales Proceeds (the “Agent Compensation”), as further described in the Addendum to this Sub-Placement Agent
Agreement (the “Agreement”). The Agent shall not be responsible for any fees imposed by any governmental or self-regulatory
organization on the Fund or the Distributor in respect of such sales. The Distributor may pay the Agent Compensation to the Agent, or
may authorize the Agent to retain the Agent Compensation from the Gross Sales Proceeds. The Agent Compensation shall be payable solely
out of the compensation the Distributor receives from the Fund pursuant to the Distribution Agreement (the “Related Compensation”).
Notwithstanding anything to the contrary in any other provision of this Agreement (or, for the avoidance of doubt, in the Addendum hereto),
the Distributor shall have no obligation to pay any portion of the Agent Compensation to the Agent, or authorize the retention by the
Agent of any portion of the Agent Compensation from the Gross Sales Proceeds, until the Distributor receives at least an equivalent amount
of Related Compensation, and the Distributor’s obligation to the Agent for the Agent Compensation is limited solely to amounts payable
out of the Related Compensation.
(e) The
Agent shall provide written confirmation to the Distributor following the close of trading on the Stock Exchange on each Offering Date
setting forth for each sale the number of Shares sold, the time of sale, the Gross Sales Price per Share, and the compensation that the
Agent is owed with respect to such sales.
(f) Settlement
for sales of the Shares pursuant to this Section 1 will occur on the business day following the date on which such sales are made
(each such day, a “Settlement Date”), unless otherwise agreed in accordance with the Distribution Agreement. On each
Settlement Date, the Shares sold through the Agent for settlement on such date shall be delivered by the Fund at the request of the Distributor
to the Agent against payment of (i) the Gross Sales Proceeds for the sale of such Shares or (ii) to the extent authorized by
the Distributor, the Gross Sales Proceeds, less the Related Compensation. If the Agent is authorized by the Distributor to retain the
Agent Compensation from the Gross Sales Proceeds for the sale of the Shares, then the Agent shall (i) pay to the Distributor an amount
equal to the Related Compensation minus the Agent Compensation in same day funds delivered to the account(s) designated by the Distributor
and (ii) remit to the Fund the Gross Sales Proceeds, less the Related Compensation. If the Distributor shall default on its obligation
to deliver the Shares on any Settlement Date, subject to the terms of Section 5 herein, the Distributor shall (A) hold the Agent
harmless against any reasonable loss, claim or damage arising from or as a result of such default by the Distributor and (B) pay
the Agent any commission to which it would otherwise be entitled absent such default. If the Agent breaches this Agreement by failing
to deliver proceeds on any Settlement Date for the Shares delivered by the Distributor, subject to the terms of Section 5 herein,
the Agent shall (A) hold the Distributor harmless against any reasonable loss, claim or damage arising from or as a result of such
default by the Agent, (B) deliver such proceeds to the Distributor as soon as practicable and (C) pay the Distributor interest
based on the effective overnight Federal Funds rate.
(g) In
connection with this Agreement and the Offerings, the Distributor shall, no more than once per calendar quarter in which the Fund and
the Distributor have requested, or anticipate requesting, that the Agent sell Shares pursuant to an Offering, provide to the Agent such
certificates and other documents, in any case, as the Agent may reasonably request upon reasonable notice (but in no event upon notice
of less than five business days) relating to authorization, capacity, enforceability and compliance matters. Any such certifications shall
be made as of the end of the calendar quarter immediately preceding the calendar quarter in which such request by the Agent is made.
(h) In
connection with this Agreement and the Offerings, the Agent will promptly notify the Fund and the Distributor of any material non-confidential claim or
complaint, any material enforcement action or other material proceeding by a regulatory authority with respect to the Fund, the Shares
or the Offerings against or directed at or to the Agent or its principals, affiliates, officers, directors, employees or agents, or any
person who controls the Agent, within the meaning of Section 15 of the Securities Act.
(i) In
connection with this Agreement and the Offerings, the Agent will promptly notify the Fund and the Distributor of any examination by any
regulatory agency or self-regulatory organization that has resulted in a material compliance deficiency in connection with the Offerings.
(j) The
Agent shall timely file with the Financial Industry Regulatory Authority, Inc. (“FINRA”) all sales literature and other
filings that may be required in connection with the Offerings.
SECTION 2. Representations
and Warranties by the Distributor. The Distributor represents, warrants to and agrees with the Agent, as of the date hereof and as
of each Offering Date and Settlement Date, that:
(a) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, the registration statement on Form N-2 (File No. 333-269889 and 811-21465)
(the “Registration Statement”) (i) is an “automatic shelf registration statement” as defined in Rule 405
under the Securities Act; (ii) has been prepared by the Fund in conformity with the requirements of the Securities Act and the Investment
Company Act of 1940, as amended, and the rules and regulations thereunder (collectively, the “1940 Act”) in all material
respects; and (iii) has been filed with the U.S. Securities and Exchange Commission (the “Commission”) under the
Securities Act and the 1940 Act; the Registration Statement sets forth the terms of the offering, sale and plan of distribution of the
Shares and contains additional information concerning the Fund and its business; no notice of objection of the Commission to the use of
the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received
by the Fund; the Registration Statement, including any amendments thereto, became effective upon filing; no stop order of the Commission
preventing or suspending the use of the Base Prospectus (as defined herein), the Prospectus Supplement (as defined herein) or the Prospectus
(as defined herein), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been
instituted or, to the Fund’s knowledge, have been threatened by the Commission. Except where the context otherwise requires, “Registration
Statement,” as used herein, means, collectively, the various parts of the registration statement, as amended at the time of
effectiveness for purposes of Section 11 of the Securities Act (the “Effective Time”), as such section applies
to the Distributor, as well as any new registration statement, post-effective amendment or new shelf registration statement relating to
the Shares, including (1) all documents filed as a part thereof or incorporated or deemed to be incorporated by reference therein,
(2) any information contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 424(b)
under the Securities Act, to the extent such information is deemed, pursuant to Rule 430B or Rule 430C under the Securities
Act, to be part of the registration statement at the time of such registration statement’s effectiveness for purposes of Section 11
of the Securities Act, as such section applies to the Distributor, and (3) any registration statement filed to register the offer
and sale of Shares pursuant to Rule 462(b) under the Securities Act. “Base Prospectus,” as used herein, means
the final prospectus filed as part of the Registration Statement, including the related statement of additional information, together
with any amendments or supplements thereto as of the date of this Agreement. Except where the context otherwise requires, “Prospectus
Supplement,” as used herein, means the final prospectus supplement, including the related statement of additional information,
relating to the Shares, filed by the Fund with the Commission pursuant to Rule 424(b) under the Securities Act, in the form furnished
by the Fund to the Distributor in connection with the offering of the Shares. Except where the context otherwise requires, “Prospectus,”
as used herein, means the Prospectus Supplement together with the Base Prospectus attached to or used with the Prospectus Supplement.
Any reference herein to the Registration Statement, the Base Prospectus, the Prospectus Supplement or the Prospectus shall be deemed to
refer to and include the documents, if any, incorporated by reference, or deemed to be incorporated by reference, therein.
(b) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, (i) the Fund is duly registered under
the 1940 Act as a closed-end management investment company; (ii) a notification of registration of the Fund as
an investment company under the 1940 Act on Form N-8A (the “1940 Act Notification”) has been prepared
by the Fund in conformity with the 1940 Act and has been filed with the Commission and, at the time of filing thereof and at the time
of filing any amendment or supplement thereto, conformed in all material respects with all applicable provisions of the 1940 Act; (iii) the
Fund has not received any notice in writing from the Commission pursuant to Section 8(e) of the 1940 Act with respect to the 1940
Act Notification or the Registration Statement (or any amendment or supplement to either of them); and (iv) no person is serving
or acting as an officer, trustee or investment adviser of the Fund except in accordance with the provisions of the 1940 Act, provided
that for purposes of the foregoing representation with respect to officers and trustees of the Fund, the Fund shall be entitled to rely
on representations from such officers and trustees.
(c) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, the Registration Statement, the 1940 Act Notification
and the Prospectus, as from time to time amended or supplemented, each complied when it became effective or was filed (as the case may
be), complies as of the date hereof and, as amended or supplemented, will comply, at each time of purchase of Shares in connection with
each Offering, and at all times during which a prospectus is required by the Securities Act to be delivered in connection with any sale
of Shares, in all material respects, with the requirements of the Securities Act and the 1940 Act; the Registration Statement did not,
as of the Effective Time, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading; at no time during the period that begins on the earlier of the date of the
Base Prospectus or the date the Base Prospectus was filed with the Commission and ends at the later of each time of purchase of Shares
in connection with each Offering or the end of the period during which a prospectus is required by the Securities Act to be delivered
in connection with any sale of Shares, did or will the Prospectus, as from time to time amended or supplemented, include an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that the Distributor does not make any representation or warranty with
respect to any statement contained in the Registration Statement, the Base Prospectus or the Prospectus in reliance upon and in conformity
with information furnished in writing by the Agent or on the Agent’s behalf to the Distributor or the Fund expressly for use in
the Registration Statement or the Prospectus (the “Agent Provided Information”). The Agent confirms that (i) the
Agent’s name on the front cover and under the headings “Prospectus Supplement Summary – The Offering” and “Plan
of Distribution” in the Prospectus Supplement and (ii) the tenth paragraph and the second sentence of the eleventh paragraph
under the heading “Plan of Distribution” in the Prospectus Supplement was the only information furnished in writing to the
Distributor or the Fund by or on behalf of the Agent expressly for use in the Registration Statement or Prospectus.
(d) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, the financial statements incorporated by reference
in the Registration Statement or the Prospectus, together with the related notes and schedules, (i) present fairly in all materials
respects the financial position of the Fund as of the dates indicated and the results of operations, cash flows and changes in shareholders’
equity of the Fund for the periods specified and (ii) have been prepared in compliance in all material respects with the requirements
of the Securities Act, the 1940 Act and the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively,
the “Exchange Act”), and in conformity in all material respects with U.S. generally accepted accounting principles
applied on a consistent basis during the periods involved; the other financial and statistical data contained or incorporated by reference
in the Registration Statement or the Prospectus are accurately and fairly presented, in all material respects, and prepared on a basis
consistent with the financial statements and books and records of the Fund in all material respects; there are no financial statements
that are required to be included or incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus by
the Securities Act, the 1940 Act or the Exchange Act that are not included or incorporated by reference as required; and the Fund does
not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not
described in the Registration Statement (excluding the exhibits thereto).
(e) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, as of the date of this Agreement, the Fund
has an authorized and outstanding capitalization as set forth in the Registration Statement, the Base Prospectus and the Prospectus and,
with respect to any issuance and sale under this Agreement, the Fund shall have as of the date of the most recent amendment or supplement
to the Registration Statement or Prospectus, an authorized and outstanding capitalization as set forth in the Registration Statement and
the Prospectus; all of the issued and outstanding shares of beneficial interest of the Fund have been duly authorized and validly issued
and are fully paid and non-assessable, have been issued in material compliance with all applicable securities laws
and were not issued in violation of any preemptive right, resale right, right of first refusal or similar right.
(f) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, (i) the Fund has been duly formed, has
legal existence as a statutory trust and is in good standing under the laws of Delaware, with full power and authority to own, lease and
operate and conduct its business as described in the Registration Statement, the Base Prospectus and the Prospectus and to issue, sell
and deliver the Shares as contemplated herein; and (ii) the Fund is duly qualified to do business as a foreign entity and is in good
standing in each jurisdiction where the conduct of its business requires such qualification, except where the failure to be so qualified
and in good standing would not, individually or in the aggregate, have a material adverse effect on the business, properties, financial
condition or results of operations of the Fund.
(g) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, (i) the Shares have been duly and validly
authorized and, when issued and delivered against payment therefor as provided herein, will be duly and validly issued, fully paid and non-assessable and free
of statutory and contractual preemptive rights, resale rights, rights of first refusal and similar rights; (ii) the Shares, when
issued and delivered against payment therefor as provided herein, will be free of any restriction upon the voting or transfer thereof
pursuant to the Fund’s Amended and Restated Agreement and Declaration of Trust, as further amended or supplemented, the Fund’s
Amended and Restated By-Laws, as further amended or supplemented, or any agreement or other instrument to which the Fund is a party; (iii) the
Common Shares, including the Shares, conform in all material respects to the description thereof, if any, contained or incorporated by
reference in the Registration Statement, the Base Prospectus or the Prospectus; (iv) the certificates for the Shares, if any, are
in due and proper form; (v) the Fund is in material compliance with the rules of the Stock Exchange, including, without limitation,
the requirements for continued listing of the Common Shares on the Stock Exchange and the Fund has not received any written notice from
the Stock Exchange regarding the delisting of the Common Shares from the Stock Exchange; and (vi) the Shares will be duly listed,
and admitted and authorized for trading, subject to official notice of issuance, on the Stock Exchange.
(h) The
Distributor has full corporate power and authority to enter into this Agreement and the transactions contemplated hereby. This Agreement
has been duly authorized, executed and delivered by the Distributor. Assuming due authorization, execution and delivery of this Agreement
by the Agent, this Agreement constitutes a valid and binding agreement of the Distributor and is enforceable against the Distributor in
accordance with its terms, except as the enforceability hereof and thereof may be limited by applicable bankruptcy, insolvency, reorganization
and similar laws affecting creditors’ rights generally and moratorium laws in effect from time to time and by equitable principles
restricting the availability of equitable remedies.
(i) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, no approval, authorization, consent or order
of or filing with any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or of
or with any self-regulatory organization or other non-governmental regulatory authority (including, without limitation,
the Stock Exchange), or approval of the shareholders of the Fund that has not already been obtained, is required in connection with the
issuance and sale of the Shares or the consummation by the Fund of the transactions contemplated hereby, other than (i) the registration
of the Shares under the Securities Act, which has been effected, (ii) the listing of the Shares with the Stock Exchange, upon official
notice of issuance, (iii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in which
the Shares are being offered through the Agent or (iv) any necessary qualification pursuant to the rules of FINRA.
(j) Based
upon the representations made by the Fund to the Distributor in the Distribution Agreement, prior to the execution of this Agreement,
the Fund has not, directly or indirectly, offered or sold any Shares by means of any “prospectus” or “free writing prospectus”
(in each case within the meaning of the Securities Act) or used any “prospectus” or “free writing prospectus”
(in each case within the meaning of the Securities Act) in connection with the offer or sale of the Shares, and from and after the execution
of this Agreement, the Fund will not, directly or indirectly, offer or sell any Shares by means of any “prospectus” or “free
writing prospectus” (in each case within the meaning of the Securities Act) or use any “prospectus” or “free writing
prospectus” (in each case within the meaning of the Securities Act) in connection with the offer or sale of the Shares, other than
the Prospectus, as amended or supplemented from time to time in accordance with the provisions of this Agreement; and the Fund is not
an “ineligible issuer” (as defined in Rule 405 under the Securities Act) as of the eligibility determination date for
purposes of Rules 164 and 433 under the Securities Act with respect to the offering of the Shares contemplated by the Registration Statement.
SECTION 3. Representations
and Warranties by the Agent. The Agent represents, warrants to and agrees with the Distributor, as of the date hereof and as of each
Offering Date and Settlement Date, that:
(a) The
Agent has full corporate power and authority to enter into this Agreement and the transactions contemplated hereby. This Agreement has
been duly authorized, executed and delivered by the Agent. Assuming due authorization, execution and delivery by the Distributor, this
Agreement constitutes a valid and binding agreement of the Agent and is enforceable against the Agent in accordance with its terms, except
as the enforceability hereof and thereof may be limited by applicable bankruptcy, insolvency, reorganization and similar laws affecting
creditors’ rights generally and moratorium laws in effect from time to time and by equitable principles restricting the availability
of equitable remedies.
(b) The
Agent Provided Information is or will be complete and accurate in all material respects and does not or will not, as from time to time
amended or supplemented, include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(c) The
Agent has adopted and implemented written policies and procedures reasonably designed to prevent violation of federal and state securities
laws, including policies and procedures that provide oversight of compliance by each registered representative of the Agent.
SECTION 4. Additional
Covenants.
(a) The
Agent hereby confirms that it is actually engaged in the investment banking and securities business and is a member in good standing with
FINRA and hereby agrees that it will undertake to comply with all applicable FINRA rules (as amended from time to time, including without
limitation, any successor provision) in connection with acting as sub-placement agent for the sale of the Shares.
The Agent further agrees that in acting as sub-placement agent for the sale of the Shares, it will comply with all
applicable laws, rules and regulations, including the applicable provisions of the Securities Act, the Exchange Act, and the 1940 Act,
and the applicable rules and regulations of the Commission thereunder, and the applicable rules and regulations of any state or any securities
exchange or self-regulatory organization having jurisdiction over the relevant Offering.
(b) The
Agent hereby agrees that in acting as sub-placement agent for the sale of the Shares, it will not use, authorize use
of, refer to, or participate in the planning for use of any written communication (as defined in Rule 405 under the Securities Act) concerning
any Offering, other than the Prospectus. The Agent further agrees that in acting as sub-placement agent for the sale
of the Shares, it is not authorized by the Distributor or the Fund or any other seller of the Shares offered pursuant to the Prospectus
to give any information or to make any representation not contained in the Prospectus in connection with the sale of such Shares.
(c) The
Distributor shall not be under any obligation to the Agent except for obligations assumed hereunder or in writing by the Distributor in
connection with any Offering. Nothing contained herein or in any communication in writing from us shall constitute the Distributor and
the Agent an association or partners with one another. If such parties should be deemed to constitute a partnership for Federal income
tax purposes, then the Agent elects to be excluded from the application of Subchapter K, Chapter 1, Subtitle A of the Internal Revenue
Code of 1986 and agrees not to take any position inconsistent with that election. The Agent authorizes the Distributor, in its discretion,
to execute and file on its behalf such evidence of that election as may be required by the Internal Revenue Service. In connection with
any Offering, each party shall be liable for its proportionate amount of any tax, claim, demand or liability that may be asserted against
it alone, based upon the claim that either of them constitutes an association, an unincorporated business or other entity, including,
in each case, its proportionate amount of any expense incurred in defending against any such tax, claim, demand or liability.
(d) The
parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any stock
split effected with respect to the Shares.
(e) The
Agent shall at all times comply with the offering requirements as set forth herein and under the heading “Plan of Distribution”
in the Prospectus.
(f) The
Agent will limit its interest in any Offering solely to the Applicable Selling Agent Commission, which shall not exceed the usual and
customary distributor’s or selling agent’s commission in the Offerings.
(g) The
Agent has not and will not, acting alone or in concert with others, initiate or direct the formation of an underwriting syndicate in any
Offering.
SECTION 5. Indemnification
and Contribution.
(a) The
Distributor agrees to indemnify, defend and hold harmless the Agent, its partners, directors and officers, and any person who controls
the Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and the successors and assigns
of all of the foregoing persons, from and against any reasonable loss, damage, expense, liability or claim (including the reasonable cost
of investigation) which the Agent or any such person may incur under the Securities Act, the 1940 Act, the Exchange Act, the common law
or otherwise, insofar as such loss, damage, expense, liability or claim (or any actions or proceedings in respect thereof) arises out
of or is based upon (i) any material breach of any representation, warranty, covenant or agreement of the Distributor contained in
this Agreement, (ii) any material violation by the Distributor of any law, rule or regulation (including any rule of any self-regulatory
organization) applicable to the Offerings, or (iii) any untrue statement or alleged untrue statement of a material fact appearing
in the Registration Statement or Prospectus or omission or alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances in which they were made, not misleading, except to the extent
such statements were included in the Registration Statement or Prospectus in reliance upon and in conformity with the Agent Provided Information.
(b) The
Agent agrees to indemnify, defend and hold harmless the Distributor, the Fund, their partners, trustees, directors and officers, and any
person who controls the Distributor or the Fund within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act, and the successors and assigns of all of the foregoing persons, from and against any loss, damage, expense, liability or
claim (including the reasonable cost of investigation) which the Distributor, the Fund or any such other person may incur under the Securities
Act, the 1940 Act, the Exchange Act, the common law or otherwise, insofar as such loss, damage, expense, liability or claim (or any actions
or proceedings in respect thereof) arises out of or is based upon (i) any material breach of any representation, warranty, covenant
or agreement of the Agent contained in this Agreement or (ii) any material violation by the Agent of any law, rule or regulation
(including any rule of any self-regulatory organization), or (iii) any untrue statement or alleged untrue statement or omission or
alleged omission made in the Registration Statement or the Prospectus in reliance upon and in conformity with the Agent Provided Information.
(c) An
indemnified person under Section 5 of this Agreement (the “Indemnified Party”) shall give written notice to the
other party (the “Indemnifying Party”) of any loss, damage, expense, liability or claim in respect of which the Indemnifying
Party has a duty to indemnify such Indemnified Party under Section 5(a) or (b) of this Agreement (a “Claim”),
specifying in reasonable detail the nature of the loss, damage, expense, liability or claim for which indemnification is sought, except
that any delay or failure so to notify such Indemnifying Party shall only relieve such Indemnifying Party of its obligations hereunder
to the extent, if at all, that such Indemnifying Party is actually prejudiced by reason of such delay or failure.
(d) If
a Claim results from any action, suit or proceeding brought or asserted against an Indemnified Party, the Indemnifying Party shall assume
the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees
and expenses. The Indemnified Party shall have the right to employ separate counsel in such action, suit or proceeding and participate
in such defense thereof, but the fees and expenses of such separate counsel shall be at the expense of the Indemnified Party unless (i) the
Indemnifying Party has agreed in writing to pay such fees and expenses, (ii) the Indemnifying Party has failed within a reasonable
time to assume the defense and employ counsel or (iii) the named parties to any such action, suit or proceeding (including any impleaded
parties) include both such Indemnified Party and Indemnifying Party and such Indemnified Party shall have been advised by its counsel
that representation of such Indemnified Party and Indemnifying Party by the same counsel would be inappropriate under applicable standards
of professional conduct (whether or not such representation by the same counsel has been proposed) due to actual or potential differing
interests between the Indemnifying Party and the Indemnified Party (in which case the Indemnifying Party shall not have the right to assume
the defense of such action, suit or proceeding on behalf of such Indemnified Party). It is understood, however, that the Indemnifying
Party shall, in connection with any one action, suit or proceeding or separate but substantially similar or related actions, suits or
proceedings in the same jurisdiction arising out of the same general allegations or circumstances be liable for the reasonable fees and
expenses of only one separate firm of attorneys (in addition to any local counsel) at any time for all such Indemnified Parties not having
actual or potential differing interests with the Indemnifying Party or among themselves, which firm shall be designated in writing by
an authorized representative of such parties and that all such fees and expenses shall be reimbursed promptly as they are incurred. The
Indemnifying Party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent,
but if settled with such written consent or if there be a final judgment for the plaintiff in any such action, suit or proceeding, the
Indemnifying Party agrees to indemnify and hold harmless any Indemnified Party from and against any loss, liability, damage or expense
by reason by such settlement or judgment.
(e) With
respect to any Claim not within Paragraph (d) of Section 5 hereof, the Indemnifying Party shall have 20 days from receipt of
notice from the Indemnified Party of such Claim within which to respond thereto. If the Indemnifying Party does not respond within such twenty-day period, it
shall be deemed to have accepted responsibility to make payment and shall have no further right to contest the validity of such Claim.
If the Indemnifying Party notifies the Indemnified Party within such twenty-day period that it rejects such Claim
in whole or in part, the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party under applicable
law.
(f) If
the indemnification provided for in this Section 5 is unavailable to an Indemnified Party or insufficient to hold an Indemnified
Party harmless in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable Indemnifying
Party shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, damages, expenses, liabilities
or claims in such proportion as is appropriate to reflect (i) the relative benefits received by the Indemnified Party, on the one
hand, and the Indemnifying Party, on the other hand, from the offering of the Shares; or (ii) if, but only if, the allocation provided
for in clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
referred to in clause (i) but also the relative fault of the Indemnified Party, on the one hand, and of the Indemnifying Party, on
the other, in connection with any statements or omissions or other matters which resulted in such losses, damages, expenses, liabilities
or claims, as well as any other relevant equitable considerations. The relative benefits received by the Distributor, on the one hand,
and the Agent, on the other, shall be deemed to be in the same respective proportions as the total compensation received by the Distributor
from sales of the Shares bears to the total compensation received by the Agent from sales of the Shares. The relative fault of the parties
hereto shall be determined by reference to, among other things, whether the untrue statement or alleged untrue statement of a material
fact or omission or alleged omission relates to information supplied by such party, on one hand, or by the other party, on the other hand,
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The amount paid or payable by a party hereto as a result of the losses, damages, expenses, liabilities and claims referred to in this
subsection shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating,
preparing to defend or defending any proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant
to this Section 5 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable
considerations referred to in this subsection (f). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. Notwithstanding
the foregoing provisions of this subsection (f), the Agent shall not be required to contribute any amount in excess of the commissions
received by it under this Agreement.
(g) The
indemnity and contribution agreements contained in this Section 5 and the covenants, warranties and representations of the parties
contained in this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Agent, its
partners, directors or officers, or any person (including each partner, officer or director of such person) who controls the Agent within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or by or on behalf of the Distributor, its
directors or officers, or any person who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act, and shall survive any termination of this Agreement or the issuance and delivery of the Shares.
(h) IN
NO EVENT WILL ANY PARTY TO THIS AGREEMENT BE LIABLE TO ANY OTHER PERSON OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL
OR INDIRECT DAMAGES (INCLUDING BUT NOT LIMITED TO LOST PROFITS), EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES.
SECTION 6. Termination.
(a) This
Agreement shall continue in full force and effect until terminated by either party, including by written instruction by the Fund to the
Distributor, by five (5) days’ written notice to the other party; provided that if this Agreement has become effective with
respect to any Offering pursuant to this Agreement, this Agreement may not be terminated by either party with respect to such Offering;
provided further that this Agreement shall terminate automatically upon termination of the Distribution Agreement.
(b) This
Agreement shall remain in full force and effect unless terminated pursuant to Section 6(a) hereof or otherwise by mutual agreement
of the parties; provided that any such termination by mutual agreement shall in all cases be deemed to provide that Section 5 shall
remain in full force and effect.
(c) Any
termination of this Agreement shall be effective on the date specified in such notice of termination; provided that in any event such
termination shall not be effective until any earlier than the close of business on the fifth day after receipt of such notice by the Distributor
or the Agent, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of the Shares, such sale shall
settle in accordance with the provisions of Section 1 of this Agreement.
SECTION 7. Notices.
Except as otherwise herein provided, all statements, requests, notices and agreements under this Agreement shall be in writing and delivered
by hand, overnight courier, mail or email and shall be sufficient in all respects if delivered or sent to:
If to the Distributor:
Foreside Fund Services, LLC
Three Canal Plaza, Suite 100
Portland, Maine 04101
Attn: Legal Department
Email: legal@foreside.com
For all operational notices or communications: etp-services@foreside.com
If to the Agent:
UBS Securities LLC
1285 Avenue of the Americas
New York, New York 10019
Attn: Saawan Pathange
Email: saawan.pathange@ubs.com
Each party to this Agreement may change such
address for notices by sending to the parties to this Agreement written notice of a new address for such purpose.
SECTION 8. Parties
in Interest. This Agreement has been and is made solely for the benefit of the Distributor, the Fund and the Agent and, to the
extent provided in Section 5 of this Agreement, the partners, trustees, directors, officers and controlling persons (within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) referred to in such section, and their
respective successors and assigns. No other person, partnership, association or corporation (including a purchaser, as such
purchaser, from the Distributor) shall acquire or have any right under or by virtue of this Agreement.
SECTION 9. No
Fiduciary Relationship. The Distributor hereby acknowledges that the Agent is acting solely as sub-placement agent in
connection with the sale of the Shares and that the Agent is acting pursuant to a contractual relationship created solely by this Agreement
entered into on an arm’s length basis, and in no event do the parties intend that the Agent act or be responsible as a fiduciary
to the Distributor or the Fund, their respective management, shareholders or creditors, or any other person in connection with any activity
that the Agent may undertake or have undertaken in furtherance of the sale of the Shares, either before or after the date hereof.
SECTION 10. Entire
Agreement. This Agreement constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings,
both written and oral, among the parties hereto with regard to the subject matter hereof.
SECTION 11. Counterparts;
Heading. This Agreement may be signed by the parties in one or more counterparts which together shall constitute one and the same agreement
among the parties. The Section headings in this Agreement have been inserted as a matter of convenience of reference and are not a part
of this Agreement.
SECTION 12. Law;
Construction. This Agreement and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of or in any way
relating to this Agreement (“Dispute”), directly or indirectly, shall be governed by, and construed in accordance with,
the internal laws of the State of New York.
SECTION 13. Submission
to Jurisdiction. Except as set forth below, no Dispute may be commenced, prosecuted or continued in any court other than the courts
of the State of New York located in the City and County of New York or in the United States District Court for the Southern District of
New York, which courts shall have jurisdiction over the adjudication of such matters, and each party hereto consents to the jurisdiction
of such courts and personal service with respect thereto. Each party hereto hereby consents to personal jurisdiction, service and venue
in any court in which any Dispute arising out of or in any way relating to this Agreement is brought by any third party against any Indemnified
Party. Each party hereto (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates)
waives all right to trial by jury in any action, proceeding or counterclaim (whether based upon contract, tort or otherwise) in any way
arising out of or relating to this Agreement. Each party hereto agrees that a final judgment in any such action, proceeding or counterclaim
brought in any such court shall be conclusive and binding upon such party and may be enforced in any other courts of the jurisdiction
of which such party is or may be subject, by suit upon such judgment.
SECTION 14. Successors
and Assigns. This Agreement shall be binding upon the Distributor and the Agent and their successors and permitted assigns and any
successor or permitted assign of any substantial portion of the Distributor’s or the Agent’s respective businesses and/or
assets.
This Agreement may
not be transferred or assigned without the consent of the non-transferring or non-assigning party; provided,
however, that no such consent shall be required to transfer or assign this Agreement to an entity controlling, controlled by or
under common control with, the transferring or assigning party.
SECTION 15. Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law. If, however, any provision of this Agreement is held, under applicable law, to be invalid, illegal or unenforceable in any respect,
such provision shall be ineffective only to the extent of such invalidity, and the validity, legality and enforceability of the remaining
provisions of this Agreement shall not be affected or impaired in any way and shall be interpreted to give effect to the intent of the
parties manifested thereby.
SECTION 16. Investigations
and Proceedings. The parties to this Agreement agree to cooperate fully in any securities regulatory investigation or proceeding or
any judicial proceeding with respect to each party’s activities under this Agreement and promptly to notify the other party of any
such investigation or proceeding.
SECTION 17. Modification,
Waiver and Amendment. No modification, alteration or amendment of this Agreement will be valid or binding unless in writing and signed
by all parties. No waiver of any term or condition of this Agreement will be construed as a waiver of any other term or condition; nor
will any waiver of any default or breach under this Agreement be construed as a waiver of any other default or breach. No waiver will
be binding unless in writing and signed by the party waiving the term, condition, default or breach. Any failure or delay by any party
to enforce any of its rights under this Agreement will not be deemed a continuing waiver or modification hereof and such party, within
the time provided by law, may commence appropriate legal proceedings to enforce any or all of such right.
[The remainder of this
page is intentionally left blank]
If the foregoing correctly
sets forth the understanding between the Distributor and the Agent, please so indicate in the space provided below for that purpose, whereupon
this Agreement and your acceptance shall constitute a binding agreement between the Distributor and the Agent. Alternatively, the execution
of this Agreement by the Distributor and the acceptance by or on behalf of the Agent may be evidenced by an exchange of telegraphic or
other written communications.
|
Very truly yours, |
|
|
|
FORESIDE FUND SERVICES, LLC |
|
|
|
|
By: |
/s/ Teresa Cowan |
|
Name: |
Teresa Cowan |
|
Title: |
President |
ACCEPTED as of the date
first above written
UBS SECURITIES LLC
(as sub-placement agent)
By: |
/s/ Saawan Pathange |
|
Name: |
Saawan Pathange |
|
Title: |
Managing Director |
|
By: |
/s/ YiLin Anderson |
|
Name: |
YiLin Anderson |
|
Title: |
Executive Director |
|
[Signature Page to Sub-Placement Agent Agreement
for CBRE Global Real Estate Income Fund]
ADDENDUM
TO
SUB-PLACEMENT AGENT AGREEMENT
BETWEEN
FORESIDE FUND SERVICES,
LLC
AND
UBS SECURITIES LLC
Compensation payable to
the Agent for acting as a sub-placement agent with respect to a specified sale of Shares pursuant to this Agreement
shall be determined by multiplying the Gross Sales Proceeds by the Applicable Selling Agent Commission as set forth below:
Applicable
Selling Agent
Commission
0.80%
Where:
“Gross Sales Proceeds”
with respect to each sale of Shares shall be the Gross Sales Price multiplied by the number of Shares sold;
“Gross Sales Price”
with respect to each sale of Shares sold pursuant to this Agreement shall be the gross sales price per share of such Shares.
Exhibit (n)
Consent of Independent Registered Public Accounting
Firm
We consent to the use of our report
dated February 28, 2024, with respect to the financial statements and financial highlights of CBRE Global Real Estate Income Fund, incorporated herein
by reference.
Philadelphia, Pennsylvania
September 13, 2024
Exhibit (s)
Calculation of Filing Fee Tables
Form N-2
(Form Type)
CBRE Global Real Estate Income Fund
(Exact Name of
Registrant as Specified in its Charter)
Table 1: Newly
Registered and Carry Forward Securities
|
Security
Type |
Security
Class
Title |
Fee
Calculation
or Carry
Forward
Rule |
Amount
Registered |
Proposed
Maximum
Offering
Price Per
Unit |
Maximum
Aggregate
Offering
Price |
Fee
Rate |
Amount of
Registration
Fee |
Carry
Forward
Form
Type |
Carry
Forward
File
Number |
Carry
Forward
Initial
effective
date |
Filing Fee
Previously Paid in
Connection with
Unsold Securities to
be Carried
Forward |
Newly Registered Securities |
Fees to Be
Paid |
Equity |
Common Shares of Beneficial Interest, par value $0.001 per share |
Rule 457(c) |
40,000,000 |
$6.36(1) |
$254,400,000 |
$110.20 |
$28,034.88 |
|
|
|
|
Fees
Previously
Paid |
|
|
|
|
|
|
|
|
|
|
|
|
Carry Forward Securities |
Carry Forward Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Offering Amounts |
|
$254,400,000 |
|
$28,034.88 |
|
|
|
|
|
Total Fees Previously Paid |
|
|
|
$0 |
|
|
|
|
|
Total Fee Offsets |
|
|
|
$0 |
|
|
|
|
|
Net Fee Due |
|
|
|
$28,034.88 |
|
|
|
|
(1) | Based on the average of the high and low prices for the Trust’s
Common Shares as reported on the New York Stock Exchange, Inc. on September 11, 2024. |
Exhibit (t)
POWER OF ATTORNEY
Each
of the undersigned, in his or her capacity as a trustee of the CBRE Global Real Estate Income Fund (the “Trust”), a statutory
trust formed under the laws of the State of Delaware (the “Trust”), hereby constitutes and appoints Joseph P. Smith and Jonathan
A. Blome, and each of them, his or her true and lawful attorneys-in-fact and agents, each with full power and authority (acting alone
and without the other), for him or her and on his or her behalf and in his or her name, place and stead, in any and all capacities, to
sign, execute and file the Trust’s Registration Statement on Form N-2 under the Securities Act of 1933 Act and the Investment Company
Act of 1940 registering shares of the Trust, including any post-effective amendments thereto, with all exhibits, and any and all other
documents required to be filed with any regulatory authority, federal or state, relating to the registration thereof, or the issuance
of shares thereof, without limitation, granting unto such attorneys and agents, and each of them, full power and authority to do and perform
each and every act and thing requisite and necessary to be done in and about the premises in order to effectuate the same as fully to
all intents and purposes as he or she might or could do if personally present, hereby ratifying and confirming all that said attorneys-in-fact
and agents, or any of them, may lawfully do or cause to be done by virtue hereof.
This
Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original, but which taken together shall
constitute one instrument.
IN
WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney this 11th day of September, 2024.
|
/s/ John Bartholdson |
|
/s/ T. Ritson Ferguson |
|
|
John Bartholdson |
|
T. Ritson Ferguson |
|
|
|
|
|
|
|
/s/ Peter Finnerty |
|
/s/ Leslie E. Greis |
|
|
Peter Finnerty |
|
Leslie E. Greis |
|
|
|
|
|
|
|
/s/ Asuka Nakahara |
|
/s/ Heidi Stam |
|
|
Asuka Nakahara |
|
Heidi Stam |
|
v3.24.2.u1
N-2
|
Sep. 13, 2024 |
Cover [Abstract] |
|
Entity Central Index Key |
0001268884
|
Amendment Flag |
false
|
Document Type |
POS EX
|
Entity Registrant Name |
CBRE Global Real Estate Income Fund
|
Entity Address, Address Line One |
555
East Lancaster Avenue
|
Entity Address, Address Line Two |
Suite 120
|
Entity Address, City or Town |
Radnor
|
Entity Address, State or Province |
PA
|
Entity Address, Postal Zip Code |
19087
|
No Substantive Changes, 462(c) |
false
|
Exhibits Only, 462(d) |
true
|
Entity Well-known Seasoned Issuer |
Yes
|
Entity Emerging Growth Company |
false
|
Business Contact [Member] |
|
Cover [Abstract] |
|
Entity Address, Address Line One |
555 East Lancaster
Avenue
|
Entity Address, Address Line Two |
Suite 120
|
Entity Address, City or Town |
Radnor
|
Entity Address, State or Province |
PA
|
Entity Address, Postal Zip Code |
19087
|
City Area Code |
(877)
|
Local Phone Number |
711-4272
|
Contact Personnel Name |
Joseph P. Smith
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 405
+ Details
Name: |
dei_EntityWellKnownSeasonedIssuer |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 462 -Subsection d
+ Details
Name: |
dei_ExhibitsOnly462d |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 462 -Subsection c
+ Details
Name: |
dei_NoSubstantiveChanges462c |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
CBRE Global Real Estate ... (NYSE:IGR)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
CBRE Global Real Estate ... (NYSE:IGR)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024